<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN" "https://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="sps-1.9" dtd-version="1.1" xml:lang="pt" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">abc</journal-id>
      <journal-title-group>
        <journal-title>Arquivos Brasileiros de Cardiologia</journal-title>
        <abbrev-journal-title abbrev-type="publisher">Arq. Bras. Cardiol.</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0066-782X</issn>
      <issn pub-type="epub">1678-4170</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Cardiologia - SBC</publisher-name>
        <publisher-loc>S&#227;o Paulo, SP, Brazil</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v3">P5xshLvBDMpb534HPGLrRvH</article-id>
      <article-id pub-id-type="other">00011</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v2">S0066-782X2010000100011</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v1">S0066-782X(10)09400111</article-id>
      <article-id pub-id-type="doi">10.1590/S0066-782X2010000100011</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Artigos Originais</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Remodelamento card&#237;aco: an&#225;lise seriada e &#237;ndices de detec&#231;&#227;o precoce de disfun&#231;&#227;o ventricular</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Mendes</surname>
            <given-names>Olga de Castro</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Campos</surname>
            <given-names>Dijon Henrique S. de</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Damatto</surname>
            <given-names>Ricardo Luiz</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sugizaki</surname>
            <given-names>M&#225;rio Mateus</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
          <xref ref-type="aff" rid="aff02"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Padovani</surname>
            <given-names>Carlos Roberto</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Okoshi</surname>
            <given-names>Katashi</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cicogna</surname>
            <given-names>Ant&#244;nio Carlos</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
      </contrib-group>
      <aff id="aff02">
        <addr-line>
          <named-content content-type="city">Bauru</named-content>
          <named-content content-type="state">S&#227;o Paulo</named-content>
        </addr-line>
        <institution content-type="orgname">Faculdades Integradas de Bauru</institution>
        <country country="BR">Brazil</country>
      </aff>
      <aff id="aff01">
        <addr-line>
          <named-content content-type="city">Botucatu</named-content>
          <named-content content-type="state">S&#227;o Paulo</named-content>
        </addr-line>
        <institution content-type="orgname">Universidade Estadual Paulista</institution>
        <institution content-type="orgdiv1">Faculdade de Medicina </institution>
        <institution content-type="orgdiv2">Departamento de Cl&#237;nica M&#233;dica</institution>
        <country country="BR">Brazil</country>
      </aff>
      <pub-date date-type="collection" publication-format="electronic">
        <month>01</month>
        <year>2010</year>
      </pub-date>
      <volume>94</volume>
      <issue>1</issue>
      <fpage>62</fpage>
      <lpage>70</lpage>
      <history>
        <date date-type="accepted">
          <day>05</day>
          <month>06</month>
          <year>2009</year>
        </date>
        <date date-type="rev-recd">
          <day>23</day>
          <month>03</month>
          <year>2009</year>
        </date>
        <date date-type="received">
          <day>05</day>
          <month>11</month>
          <year>2008</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/" xml:lang="en">
          <license-p>This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>FUNDAMENTO: A estenose a&#243;rtica supravalvar (EAo) &#233; utilizada para o estudo da remodela&#231;&#227;o card&#237;aca (RC) por sobrecarga press&#243;rica. Nesse modelo, n&#227;o est&#227;o claramente estabelecidos o comportamento da RC desde a fase inicial, nem os melhores par&#226;metros para a identifica&#231;&#227;o da disfun&#231;&#227;o ventricular. OBJETIVOS: 1) Caracterizar, precoce e evolutivamente, as modifica&#231;&#245;es morfofuncionais durante a RC em ratos com EAo e 2) identificar o &#237;ndice mais sens&#237;vel para detec&#231;&#227;o do momento do aparecimento da disfun&#231;&#227;o diast&#243;lica e sist&#243;lica do ventr&#237;culo esquerdo (VE). M&#201;TODOS: Ratos Wistar foram divididos em dois grupos - controle (GC, n=13) e EAo (GEAo, n=24) - e estudados nas 3&#170;, 6&#170;, 12&#170; e 18&#170; semanas p&#243;s-cirurgia. Os cora&#231;&#245;es foram analisados por meio de ecocardiograma (ECO). RESULTADOS: Ao final do experimento, as rela&#231;&#245;es do VE, do ventr&#237;culo direito e dos &#225;trios com o peso corporal final foram aumentadas no GEAo. O ECO mostrou que o &#225;trio esquerdo sofreu uma remodela&#231;&#227;o significativa a partir da 6&#170; semana. No GEAo, a porcentagem de encurtamento endoc&#225;rdico apresentou queda significativa a partir da 12&#170; semana e a porcentagem de encurtamento mesoc&#225;rdico, na 18&#170; semana. A rela&#231;&#227;o onda E e onda A (E/A) foi superior no GC em compara&#231;&#227;o ao GEAo em todos os momentos analisados. CONCLUS&#213;ES: O ventr&#237;culo esquerdo dos ratos com EAo, durante o processo de remodela&#231;&#227;o, apresentou hipertrofia conc&#234;ntrica, disfun&#231;&#227;o diast&#243;lica precoce e melhoria da fun&#231;&#227;o sist&#243;lica, com posterior deteriora&#231;&#227;o do desempenho. Al&#233;m disso, constatou-se que os &#237;ndices ecocardiogr&#225;ficos mais sens&#237;veis para a detec&#231;&#227;o da disfun&#231;&#227;o diast&#243;lica e sist&#243;lica s&#227;o, respectivamente, a rela&#231;&#227;o E/A e a porcentagem de encurtamento endoc&#225;rdico.</p>
      </abstract>
      <kwd-group xml:lang="pt" kwd-group-type="author-generated">
        <kwd>Estenose A&#243;rtica Supravalvar</kwd>
        <kwd>Remodela&#231;&#227;o Ventricular</kwd>
        <kwd>Ecocardiografia</kwd>
        <kwd>Ratos</kwd>
        <kwd>Disfun&#231;&#227;o Ventricular</kwd>
      </kwd-group>
      <pub-date publication-format="electronic" date-type="pub">
        <day>22</day>
        <month>09</month>
        <year>2010</year>
      </pub-date>
    </article-meta>
  </front>
  <body>
    <p>ARTIGO ORIGINAL </p>
    <p> EXPERIMENTAL</p>
    <p>
      <bold>Remodelamento card&#237;aco: an&#225;lise seriada e &#237;ndices de detec&#231;&#227;o precoce de disfun&#231;&#227;o ventricular</bold>
    </p>
    <p>
      <bold>Olga de Castro Mendes<sup>I, II</sup>; Dijon Henrique S. de Campos<sup>I</sup>; Ricardo Luiz Damatto<sup>I</sup>; M&#225;rio Mateus Sugizaki<sup>I, II</sup>; Carlos Roberto Padovani<sup>I</sup>; Katashi Okoshi<sup>I</sup>, Ant&#244;nio Carlos Cicogna<sup>I</sup></bold>
    </p>
    <p><sup>I</sup>Departamento de Cl&#237;nica M&#233;dica - Faculdade de Medicina FMB - UNESP, BotucatuSP, Brasil </p>
    <p><sup>II</sup>Faculdades Integradas de Bauru, Bauru, SP, Brasil</p>
    <p>
      <xref ref-type="corresp" rid="back">Correspond&#234;ncia</xref>
    </p>
    <p>
      <bold>RESUMO</bold>
    </p>
    <p><bold>FUNDAMENTO: </bold> A estenose a&#243;rtica supravalvar (EAo) &#233; utilizada para o estudo da remodela&#231;&#227;o card&#237;aca (RC) por sobrecarga press&#243;rica. Nesse modelo, n&#227;o est&#227;o claramente estabelecidos o comportamento da RC desde a fase inicial, nem os melhores par&#226;metros para a identifica&#231;&#227;o da disfun&#231;&#227;o ventricular. </p>
    <p><bold>OBJETIVOS: </bold> 1) Caracterizar, precoce e evolutivamente, as modifica&#231;&#245;es morfofuncionais durante a RC em ratos com EAo e 2) identificar o &#237;ndice mais sens&#237;vel para detec&#231;&#227;o do momento do aparecimento da disfun&#231;&#227;o diast&#243;lica e sist&#243;lica do ventr&#237;culo esquerdo (VE). </p>
    <p><bold>M&#201;TODOS: </bold> Ratos Wistar foram divididos em dois grupos - controle (GC, n=13) e EAo (GEAo, n=24) - e estudados nas 3&#170;, 6&#170;, 12&#170; e 18&#170; semanas p&#243;s-cirurgia. Os cora&#231;&#245;es foram analisados por meio de ecocardiograma (ECO). </p>
    <p><bold>RESULTADOS: </bold> Ao final do experimento, as rela&#231;&#245;es do VE, do ventr&#237;culo direito e dos &#225;trios com o peso corporal final foram aumentadas no GEAo. O ECO mostrou que o &#225;trio esquerdo sofreu uma remodela&#231;&#227;o significativa a partir da 6&#170; semana. No GEAo, a porcentagem de encurtamento endoc&#225;rdico apresentou queda significativa a partir da 12&#170; semana e a porcentagem de encurtamento mesoc&#225;rdico, na 18&#170; semana. A rela&#231;&#227;o onda E e onda A (E/A) foi superior no GC em compara&#231;&#227;o ao GEAo em todos os momentos analisados. </p>
    <p><bold>CONCLUS&#213;ES: </bold> O ventr&#237;culo esquerdo dos ratos com EAo, durante o processo de remodela&#231;&#227;o, apresentou hipertrofia conc&#234;ntrica, disfun&#231;&#227;o diast&#243;lica precoce e melhoria da fun&#231;&#227;o sist&#243;lica, com posterior deteriora&#231;&#227;o do desempenho. Al&#233;m disso, constatou-se que os &#237;ndices ecocardiogr&#225;ficos mais sens&#237;veis para a detec&#231;&#227;o da disfun&#231;&#227;o diast&#243;lica e sist&#243;lica s&#227;o, respectivamente, a rela&#231;&#227;o E/A e a porcentagem de encurtamento endoc&#225;rdico.</p>
    <p><bold>Palavras-chave: </bold> Estenose A&#243;rtica Supravalvar, Remodela&#231;&#227;o Ventricular, Ecocardiografia, Ratos, Disfun&#231;&#227;o Ventricular / Medi&#231;&#227;o de Risco.</p>
    <p>
      <bold>Introdu&#231;&#227;o</bold>
    </p>
    <p>Remodela&#231;&#227;o card&#237;aca (RC) &#233; uma altera&#231;&#227;o na express&#227;o g&#234;nica em resposta a uma agress&#227;o, resultando em mudan&#231;as moleculares, celulares e intersticiais mioc&#225;rdicas, e que se expressa por varia&#231;&#245;es no tamanho, forma e fun&#231;&#227;o do cora&#231;&#227;o<sup>1</sup>. &#201; tamb&#233;m um mecanismo adaptativo &#224; sobrecarga hemodin&#226;mica, permitindo ao cora&#231;&#227;o manter suas fun&#231;&#245;es em vig&#234;ncia de aumento de carga<sup>2-4</sup>. &#201; considerado fator de risco para o desenvolvimento de disfun&#231;&#227;o ventricular e insufici&#234;ncia card&#237;aca (IC)<sup>5</sup>.</p>
    <p>Diversos modelos experimentais t&#234;m sido propostos para o estudo da RC por sobrecarga press&#243;rica, como a estenose a&#243;rtica supravalvar (EAo) em ratos<sup>6-8</sup>. Quando a constri&#231;&#227;o a&#243;rtica &#233; realizada em animais jovens, a sobrecarga press&#243;rica inicial &#233; leve, acentuando-se com o crescimento. As vantagens da EAo s&#227;o: o desenvolvimento gradual de RC, associado, a curto prazo, &#224; melhoria da fun&#231;&#227;o sist&#243;lica; aus&#234;ncia de severas les&#245;es anat&#244;micas mioc&#225;rdicas; e baixo custo de manuten&#231;&#227;o<sup>9</sup>. Em torno da 20&#170; semana de EAo ocorre a deteriora&#231;&#227;o do desempenho sist&#243;lico e IC<sup>10-13</sup>. Esse modelo assemelha-se parcialmente &#224; EAo no homem<sup>11</sup>.</p>
    <p>Experimentos em nosso laborat&#243;rio, realizados em ratos com EAo, avaliaram aspectos morfofuncionais card&#237;acos, por meio de ecocardiograma (ECO), em diferentes per&#237;odos da RC, constatando fun&#231;&#227;o sist&#243;lica supranormal na 6&#170; ou 8&#170; semana<sup>4,9,12</sup>, disfun&#231;&#227;o diast&#243;lica a partir da 12&#170; semana<sup>9</sup> e deteriora&#231;&#227;o do desempenho sist&#243;lico na 21&#170; semana, sendo inclu&#237;dos nesta &#250;ltima leva animais com sinais de insufici&#234;ncia card&#237;aca<sup>9</sup>. Alguns autores, utilizando avalia&#231;&#227;o hemodin&#226;mica, verificaram aumento na press&#227;o diast&#243;lica final do ventr&#237;culo esquerdo (VE) ap&#243;s a 6&#170; semana - em contraste, a avalia&#231;&#227;o da fun&#231;&#227;o diast&#243;lica por ECO mostrou-se inalterada<sup>13</sup>. Litwin e cols.<sup>8</sup> avaliando, por meio de ECO, ratos com EAO nas 6&#170;, 12&#170; e 18&#170; semanas, observaram disfun&#231;&#227;o diast&#243;lica a partir da 6&#170; semana e deteriora&#231;&#227;o no desempenho sist&#243;lico na 18&#170; semana.</p>
    <p>A an&#225;lise dos trabalhos citados mostra controv&#233;rsias de resultados e aus&#234;ncia de uma avalia&#231;&#227;o em um per&#237;odo mais inicial p&#243;s-indu&#231;&#227;o de EAo. O objetivo do trabalho foi caracterizar, precoce e evolutivamente, as modifica&#231;&#245;es morfofuncionais durante a RC em ratos com EAo, procurando identificar o &#237;ndice mais sens&#237;vel para detec&#231;&#227;o do momento do aparecimento da disfun&#231;&#227;o diast&#243;lica e sist&#243;lica do ventr&#237;culo esquerdo.</p>
    <p>
      <bold>M&#233;todos</bold>
    </p>
    <p>Os procedimentos experimentais foram aprovados pelo Comit&#234; de &#201;tica em Pesquisa Animal da Faculdade de Medicina de Botucatu-UNESP, em 19/10/2005, sob n&#186; 506/2005.</p>
    <p>
      <bold>Animais e protocolo experimental</bold>
    </p>
    <p>Foram utilizados 37 ratos Wistar, machos e jovens, provenientes do Biot&#233;rio do Departamento de Cl&#237;nica M&#233;dica da Faculdade de Medicina da UNESP-Botucatu/SP, os quais foram divididos em dois grupos: controle (GC, n=13) e estenose a&#243;rtica supravalvar (GEAo, n=24). O GEAo foi submetido &#224; cirurgia com implanta&#231;&#227;o de um clipe na art&#233;ria aorta para a indu&#231;&#227;o da EAo. O GC foi submetido &#224; mesma cirurgia, por&#233;m sem a coloca&#231;&#227;o do clipe. Foram mantidos cinco animais por caixa, em temperatura ambiente de 23&#176;C, com ciclos de luminosidade de 12 horas, alimentados com ra&#231;&#227;o padr&#227;o Purina<sup>&#174;</sup> e &#225;gua <italic>ad libitum</italic>.</p>
    <p>Os animais foram estudados nas 3&#170;, 6&#170;, 12&#170; e 18&#170; semanas ap&#243;s a cirurgia. Esses per&#237;odos s&#227;o adequados para a observa&#231;&#227;o de altera&#231;&#245;es morfofuncionais em ratos com EAo e antecedem a instala&#231;&#227;o da IC, que ocorre em torno da 20&#170; semana<sup>9,10,13</sup>.</p>
    <p>No final do experimento, procurou-se identificar sinais de IC, sendo considerado crit&#233;rio de exclus&#227;o a presen&#231;a de taquipneia associada a um dos seguintes sinais: edema, ascite, derrame pleuroperic&#225;rdico, trombo em &#225;trio esquerdo (AE) e hipertrofia do ventr&#237;culo direito (VD)<sup>14</sup>.</p>
    <p>Ao final da 18&#170; semana, os animais foram anestesiados com pentobarbital s&#243;dico intraperitonial (50 mg/kg) e decapitados, realizando-se ent&#227;o a an&#225;lise morfol&#243;gica card&#237;aca.</p>
    <p>
      <bold>Indu&#231;&#227;o de estenose a&#243;rtica supravalvar</bold>
    </p>
    <p>A EAo foi induzida de acordo com o m&#233;todo utilizado em nosso laborat&#243;rio<sup>4,12</sup>. Os animais, pesando de 70 a 90 g, ap&#243;s anestesia com cloridrato de ketamina (60 mg/kg) e cloridrato de xylazina (10 mg/kg) intraperitonial, foram submetidos &#224; toracotomia mediana. A aorta ascendente foi dissecada e um clipe de prata, com 0,6 mm de di&#226;metro interno, colocado aproximadamente a 3 mm da sua raiz. Os animais do GC foram submetidos &#224; mesma cirurgia, mas sem a coloca&#231;&#227;o do clipe.</p>
    <p>
      <bold>Avalia&#231;&#227;o ecocardiogr&#225;fica</bold>
    </p>
    <p>A fun&#231;&#227;o e a estrutura do cora&#231;&#227;o foram analisadas pelo ECO de acordo com metodologia utilizada em nosso laborat&#243;rio<sup>4,9,10,14</sup>. Os animais foram anestesiados com cloridrato de ketamina (50 mg/kg) e cloridrato de xylazina (1/ mg// kg) por via intraperitonial. Foi utilizado um ecocardi&#243;grafo (Philips<sup>&#174;</sup>, modelo HDI 5000) modo-M, equipado com transdutor eletr&#244;nico de 12 MHz. Foram avaliados os seguintes par&#226;metros morfol&#243;gicos do VE: di&#226;metros diast&#243;lico (DDVE) e sist&#243;lico (DSVE), espessuras diast&#243;licas e sist&#243;licas da parede posterior (EDPP e ESPP) e do septo interventricular (EDSIV e ESSIV) e massa (MASSA VE). O &#237;ndice de massa do VE (IMVE) foi determinado normalizando-se a massa do VE pelo peso corporal (PC). A espessura relativa da parede do VE (ERelVE) foi obtida pela f&#243;rmula (2xEDPP)/DDVE.</p>
    <p>A fun&#231;&#227;o sist&#243;lica do VE foi determinada pela porcentagem de encurtamento endoc&#225;rdico (&#916;D endo) e mesoc&#225;rdico (&#916;D meso), velocidade de encurtamento da parede posterior do VE (VEPP), d&#233;bito card&#237;aco (DC) e &#237;ndice card&#237;aco (InC). A &#916;D meso foi calculada pela f&#243;rmula ({[(DDVE + &#189; EDPP + &#189; EDSIV) - (DSVE + &#189; ESPP + &#189; ESSIV)] / (DDVE + &#189; EDPP + &#189; EDSIV)}); a VEPP foi determinada pela tangente m&#225;xima do movimento sist&#243;lico da parede posterior; o DC pela f&#243;rmula [(DDVE&#179; - DSVE&#179;) x frequ&#234;ncia card&#237;aca]; e o InC pela rela&#231;&#227;o do DC com o PC.</p>
    <p>A fun&#231;&#227;o diast&#243;lica foi avaliada pelas ondas E e A, rela&#231;&#227;o entre ondas E e onda A (E/A), tempos de desacelera&#231;&#227;o da onda E (TDE) e de relaxamento isovolum&#233;trico do VE (TRIV)<sup>15,16</sup>.</p>
    <p>
      <bold>An&#225;lise morfol&#243;gica</bold>
    </p>
    <p>As vari&#225;veis morfol&#243;gicas para caracterizar os animais foram: pesos corporais finais (PCF) do VE, do VD, dos &#225;trios (ATs) e as rela&#231;&#245;es VE/PCF, VD/PCF e ATs/PCF.</p>
    <p>
      <bold>An&#225;lise estat&#237;stica</bold>
    </p>
    <p>Os par&#226;metros morfol&#243;gicos foram analisados pelo teste t de Student, quando a vari&#225;vel mostrou-se aderente &#224; distribui&#231;&#227;o normal de probabilidade, e pelo teste de Mann-Whitney, quando esta caracter&#237;stica estava ausente. Para compara&#231;&#245;es dos grupos no processo evolutivo, utilizou-se o m&#233;todo de an&#225;lise de vari&#226;ncia (ANOVA) de medidas repetidas em dois grupos independentes, complementado pelo procedimento de compara&#231;&#227;o m&#250;ltipla de Bonferroni. Para a vari&#225;vel onda A, o procedimento estat&#237;stico considerou a t&#233;cnica n&#227;o param&#233;trica; para as outras vari&#225;veis, considerou-se a t&#233;cnica param&#233;trica<sup>17</sup>. Em todos os testes, fixou-se em 5% (p&lt;0,05) o n&#237;vel de signific&#226;ncia. Os gr&#225;ficos apresentam os resultados em m&#233;dia e erro padr&#227;o. Os c&#225;lculos estat&#237;sticos foram realizados com o aux&#237;lio do pacote estat&#237;stico SigmaStat 3.5 for Windows version (Copyright<sup>&#169;</sup> 2006, Systat Software Inc.).</p>
    <p>
      <bold>Resultados</bold>
    </p>
    <p>Ao final do experimento, dos 24 ratos do GEAo 10 morreram (41,6%) e 2 apresentaram IC (14,28%), sendo exclu&#237;dos do estudo. No GC, ocorreram 2 mortes (15,4%). Assim, os grupos estudados foram constitu&#237;dos de 11 animais no GC e 12 no GEAo. A mortalidade observada est&#225; de acordo com outros autores que constataram taxas variando de 30 a 49%<sup>5,7,12,13</sup>.</p>
    <p>
      <bold>Caracter&#237;sticas gerais</bold>
    </p>
    <p>O peso inicial dos ratos n&#227;o diferiu, sendo 82&#177;5 g para o GC e 85&#177;5 g para o GEAo. A an&#225;lise evolutiva do peso corporal mostrou que o GC foi maior do que o GEAo somente na 12&#170; semana, com tend&#234;ncia &#224; superioridade na 18&#170; semana (p=0,07). As caracter&#237;sticas gerais dos animais ao final do experimento est&#227;o expostas na <xref ref-type="table" rid="t1">Tabela 1</xref>. O peso do VE e dos ATs e as rela&#231;&#245;es VE/PCF, VD/PCF e A/PCF foram aumentados no GEAo.</p>
    <table-wrap id="t1">
      <graphic xlink:href="1678-4170-abc-94-01-0062-00011-gt01.jpg"/></table-wrap>
    <p>
      <bold>Avalia&#231;&#227;o ecocardiogr&#225;fica dos par&#226;metros estruturais do cora&#231;&#227;o</bold>
    </p>
    <p>A <xref ref-type="table" rid="t02">Tabela 2</xref> apresenta a avalia&#231;&#227;o sequencial estrutural do cora&#231;&#227;o pelo ECO. O IMVE diminuiu nos animais do GC nas 12&#170; e 18&#170; semanas, em compara&#231;&#227;o &#224; 3&#170; semana, e n&#227;o se alterou no GEAo. O &#237;ndice foi maior no GEAo em rela&#231;&#227;o ao GC a partir da 6&#170; semana, embora na 3&#170; semana j&#225; houvesse uma tend&#234;ncia a estar aumentada no GEAo (p=0,058). O DDVE foi igual nas 6&#170;, 12&#170; e 18&#170; semanas, superiores &#224; 3&#170; semana em ambos os grupos. Essa vari&#225;vel foi menor no GEAo, quando comparada ao GC. A rela&#231;&#227;o DDVE/PC no GC e no GEAo foi maior na 3&#170; semana em rela&#231;&#227;o &#224;s demais semanas, sendo as 12&#170; e 18&#170; semanas inferiores &#224; 6&#170; semana. N&#227;o houve diferen&#231;a entre os grupos. O DSVE foi superior nas 6&#170; e 12&#170; semanas em rela&#231;&#227;o &#224; 3&#170; no GC. No GEAo, o DSVE aumentou nas 6&#170;, 12&#170; e 18&#170; semanas em rela&#231;&#227;o &#224; 3&#170;, sendo a 18&#170; diferente da 6&#170; semana. O DSVE foi menor no GEAo em rela&#231;&#227;o ao GC .</p>
    <p content-type="asset">
      <table-wrap id="t02">
        <graphic xlink:href="1678-4170-abc-94-01-0062-00011-gt02.jpg"/></table-wrap>
    </p>
    <p>As EDPP e EDSIV n&#227;o se alteraram no GC durante o per&#237;odo experimental; aumentaram nos momentos 12 e 18 em rela&#231;&#227;o aos momentos 3 e 6 nos animais do GEAo. Esses par&#226;metros foram superiores no GEAo em rela&#231;&#227;o ao GC em todos os momentos. A ErelVE n&#227;o se alterou no GC; a 18&#170; semana diferiu da 6&#170; semana no GEAo. Essa vari&#225;vel foi maior no GEAo do que o GC em todos as semanas. N&#227;o houve varia&#231;&#227;o do AE no GC, embora houvesse uma tend&#234;ncia a ser maior nas 12&#170; (p=0,075) e 18&#170; (p=0,063) semanas em rela&#231;&#227;o &#224; 3&#170; semana; no GEAo, o AE foi maior a partir da semana 6, n&#227;o sofrendo posterior varia&#231;&#227;o. O AE apresentou valores mais elevados no GEAo do que no GC a partir da 6&#170; semana. A rela&#231;&#227;o AE/PC foi inferior nas 6&#170;, 12&#170; e 18&#170; semanas - menores que a semana 6 em ambos os grupos quando comparadas &#224; 3&#170; e &#224;s 12&#170; e 18&#170; semanas. Essa rela&#231;&#227;o foi maior no GEAo que no GC em todos os per&#237;odos. O AO no GC nas 6&#170; e 12&#170; semanas foi diferente da 3&#170; semana. A 18&#170; semana diferiu de todas as anteriores. No GEAo, as 6&#170;, 12&#170; e 18&#170; semanas foram superiores &#224; 3&#170; semana. Essa vari&#225;vel foi menor no GEAo em rela&#231;&#227;o ao GC na 18&#170; semana. N&#227;o houve varia&#231;&#227;o na rela&#231;&#227;o AE/AO entre os diferentes momentos em ambos os grupos. Embora o grupo GEAo tenha apresentado aumento do AE/AO em rela&#231;&#227;o ao GC, somente na 18&#170; semana houve uma tend&#234;ncia dos valores do GEAo serem maiores que o GC (0,07&gt;p&lt;0,13). Os dados absolutos e relativos do AE mostram que essa c&#226;mara sofreu uma remodela&#231;&#227;o significativa a partir da 6&#170; semana.</p>
    <p>
      <bold>Avalia&#231;&#227;o ecocardiogr&#225;fica das fun&#231;&#245;es sist&#243;lica e diast&#243;lica do ventr&#237;culo esquerdo</bold>
    </p>
    <p>Nas <xref ref-type="table" rid="t03">Tabelas 3</xref> e <xref ref-type="table" rid="t04">4</xref> s&#227;o descritos, respectivamente, a FC e os par&#226;metros da avalia&#231;&#227;o funcional sist&#243;lica e diast&#243;lica do VE. N&#227;o foram observadas diferen&#231;as na FC entre grupos e momentos. N&#227;o houve diferen&#231;a no &#916;D endo e meso em fun&#231;&#227;o do tempo no GC. No GEAo, a &#916;D endo da 12&#170; semana foi menor que a da 3&#170; e maior do que a da 18&#170; semana, menor que a 3&#170; e a 6&#170; semanas. A &#916;D meso no GEAo foi menor na 18&#170; semana em rela&#231;&#227;o &#224; 3&#170; e 6&#170;. As &#916;D endo e meso foram maiores no GEAo do que no GC em todos os momentos, com exce&#231;&#227;o da 18&#170; semana, em que o &#916;D meso foi igual em ambos os grupos (<xref ref-type="table" rid="t03">Tabela 3</xref>). Nas <xref ref-type="fig" rid="f1">Figuras 1</xref> e <xref ref-type="fig" rid="f2">2</xref>, pode-se visualizar que, enquanto a &#916;D endo e meso n&#227;o se alteraram no GC, no GEAo houve uma queda desses &#237;ndices durante a evolu&#231;&#227;o do processo, tornando-se significativos a partir da 12&#170; semana no &#916;D endo e na 18&#170; no &#916;D meso.</p>
    <p content-type="asset">
      <table-wrap id="t03">
        <graphic xlink:href="1678-4170-abc-94-01-0062-00011-gt03.jpg"/></table-wrap>
    </p>
    <p content-type="asset">
      <table-wrap id="t04">
        <graphic xlink:href="1678-4170-abc-94-01-0062-00011-gt04.jpg"/></table-wrap>
    </p>
    <fig id="f1">
      <graphic xlink:href="1678-4170-abc-94-01-0062-00011-gf01.jpg"/></fig>
    <fig id="f2">
      <graphic xlink:href="1678-4170-abc-94-01-0062-00011-gf02.jpg"/></fig>
    <p>A VEPP, quando avaliada intragrupo, mostrou-se significativamente maior na 18&#170; semana em rela&#231;&#227;o &#224;s 3&#170; e 6&#170; semanas no GC, e n&#227;o alterada no GEAo. Houve redu&#231;&#227;o do VEPP no GEAo em rela&#231;&#227;o ao GC na 18&#170; semana. O DC aumentou nas 12&#170; e 18&#170; semanas em rela&#231;&#227;o &#224; 3&#170; no GC, com tend&#234;ncia a ser superior na 6&#170; semana em rela&#231;&#227;o &#224; 3&#170; (p=0,083). No GEAo, as 6&#170;, 12&#170; e 18&#170; semanas foram superiores &#224; 3&#170;. Houve diferen&#231;a no DC entre grupos somente na 18&#170; semana, sendo menor no GEAo. O InC diminuiu na 12&#170; e 18&#170; semanas no GC em rela&#231;&#227;o &#224;s semanas anteriores. No GEAo, a 18&#170; semana foi menor que as 3&#170; e 6&#170; semanas. Houve uma tend&#234;ncia da 12&#170; semana ser menor que a 6&#170; semana (p=0,069). N&#227;o houve diferen&#231;a entre os grupos (<xref ref-type="table" rid="t03">Tabela 3</xref>).</p>
    <p>No GC e GEAo (<xref ref-type="table" rid="t04">Tabela 4</xref>), as ondas E e A n&#227;o apresentaram altera&#231;&#245;es nos diferentes per&#237;odos de avalia&#231;&#227;o. Enquanto a onda E foi igual intergrupos, a onda A foi maior no GEAo do que no GC em todos os per&#237;odos. A rela&#231;&#227;o E/A apresentou diminui&#231;&#227;o no GC na 18&#170; semana em rela&#231;&#227;o &#224; 3&#170;, com tend&#234;ncia a ser menor na 18&#170; semana em rela&#231;&#227;o &#224;s 6&#170; (p=0,067) e 12&#170; (p=0,095) semanas. No GEAo, n&#227;o houve diferen&#231;a entre os momentos, com tend&#234;ncia &#224; diferen&#231;a entre as 3&#170; e 18&#170; semanas (p=0,10). A rela&#231;&#227;o E/A mostrou-se superior no GC nos diferentes momentos avaliados (<xref ref-type="table" rid="t04">Tabela 4</xref> e <xref ref-type="fig" rid="f3">Figura 3</xref>). O TRIV foi semelhante no GC em todos os momentos. No GEAo, foi maior na 18&#170; semana em rela&#231;&#227;o &#224; 3&#170; e 6&#170;. N&#227;o houve diferen&#231;a entre os grupos. O TDE foi semelhante no GC. No GEAo, houve tend&#234;ncia &#224; diferen&#231;a entre as 6&#170; e 18&#170; semanas (p=0,058) e 12&#170; e 18&#170; semanas (p=0,063). O TDE foi menor no GEAo nos momentos 3, 12 e 18 em rela&#231;&#227;o ao GC.</p>
    <fig id="f3">
      <graphic xlink:href="1678-4170-abc-94-01-0062-00011-gf03.jpg"/></fig>
    <p>
      <bold>Discuss&#227;o</bold>
    </p>
    <p>Neste estudo foram avaliadas a morfologia e a fun&#231;&#227;o card&#237;aca durante o processo de remodela&#231;&#227;o em ratos submetidos &#224; EAo. O remodelamento que ocorre frente a essa agress&#227;o pode acarretar disfun&#231;&#227;o ventricular. O principal crit&#233;rio para o diagn&#243;stico dessa altera&#231;&#227;o funcional, em estudos experimentais, tem sido o n&#237;vel da press&#227;o final diast&#243;lica do VE, avaliado por m&#233;todo hemodin&#226;mico<sup>18</sup>. Entretanto, a sua determina&#231;&#227;o requer um processo invasivo, fato que prejudica estudos longitudinais. Al&#233;m disso, a cateteriza&#231;&#227;o do VE pode causar danos &#224; valva a&#243;rtica ou afetar a performance card&#237;aca<sup>19</sup>.</p>
    <p>O ECO representa uma alternativa para o estudo da fun&#231;&#227;o ventricular e pode oferecer importantes informa&#231;&#245;es sobre desempenho card&#237;aco em roedores<sup>19</sup>. Ele permite avaliar a morfologia e a fun&#231;&#227;o card&#237;aca<sup>8,19-21</sup>, a evolu&#231;&#227;o da disfun&#231;&#227;o ventricular causada por diferentes tipos de agress&#227;o<sup>22</sup> e os efeitos de diferentes interven&#231;&#245;es<sup>13,23</sup>. &#201; um m&#233;todo vers&#225;til, seguro, indolor, n&#227;o invasivo e importante para an&#225;lises seriais <italic>in vivo</italic><sup>24</sup>.</p>
    <p>Os resultados ecocardiogr&#225;ficos neste estudo mostram importantes altera&#231;&#245;es estruturais do VE durante o processo da evolu&#231;&#227;o da remodela&#231;&#227;o<sup>25</sup>. O IMVE decresceu no GC a partir da 12&#170; semana em raz&#227;o do aumento do peso corporal dos ratos; no GEAo o IMVE manteve-se est&#225;vel. Como esse par&#226;metro n&#227;o &#233; diretamente proporcional ao peso corporal, em situa&#231;&#227;o de perda e ganho de peso corporal os valores normalizados estar&#227;o aumentados ou diminu&#237;dos, respectivamente. V&#225;rios par&#226;metros indicadores de hipertrofia, como EDPP, EDSIV e ERelVE, apresentaram-se alterados a partir da 3&#170; semana e o IMVE ap&#243;s a 6&#170; semana. A an&#225;lise da ERelVE indicou que a EAo acarretou, precocemente, hipertrofia conc&#234;ntrica do VE, mantida at&#233; o final do experimento. A remodela&#231;&#227;o ventricular esquerda pelo ECO foi confirmada pela avalia&#231;&#227;o estrutural card&#237;aca ap&#243;s o sacrif&#237;cio dos ratos (<xref ref-type="table" rid="t1">Tabela 1</xref>).</p>
    <p>Al&#233;m da hipertrofia ventricular esquerda, os resultados mostram que os ratos do GEAo, no momento do sacrif&#237;cio, apresentavam uma hipertrofia do ventr&#237;culo direito avaliada pela rela&#231;&#227;o VD/PC. Apesar do diagn&#243;stico de insufici&#234;ncia card&#237;aca, nesse experimento, ter sido feito pela associa&#231;&#227;o de dois sinais cl&#237;nico-morfol&#243;gicos, descritos anteriormente, o encontro isolado do aumento nesta rela&#231;&#227;o n&#227;o significa que os ratos do GEAo estariam com insufici&#234;ncia card&#237;aca. Entretanto, os aumentos do peso atrial e da sua rela&#231;&#227;o com o peso corporal mostram que os ratos, no momento do sacrif&#237;cio, apresentavam disfun&#231;&#227;o ventricular esquerda.</p>
    <p>Os dados estruturais do VE, determinados por ECO ou p&#243;s-sacrif&#237;cio, est&#227;o de acordo com in&#250;meros trabalhos que detectaram hipertrofia ventricular em diferentes fases da RC p&#243;s-indu&#231;&#227;o de EAo<sup>4,6,8,11,12</sup>. Valores observados no DSVE s&#227;o discordantes da literatura, que n&#227;o encontrou altera&#231;&#227;o dessa vari&#225;vel no GEAo ap&#243;s a 6&#170; semana de indu&#231;&#227;o de EAo<sup>4,19</sup>.</p>
    <p>O desenvolvimento da hipertrofia ventricular esquerda foi uma resposta adaptativa &#224; eleva&#231;&#227;o da press&#227;o intraventricular &#224; EAo, j&#225; que o aumento da espessura da parede e diminui&#231;&#227;o da cavidade podem normalizar o estresse parietal e, consequentemente, a fun&#231;&#227;o ventricular. A hipertrofia conc&#234;ntrica &#233; decorrente do aumento do di&#226;metro dos mi&#243;citos com pouca ou nenhuma modifica&#231;&#227;o no comprimento celular<sup>26</sup>. Concomitantemente, observam-se modifica&#231;&#245;es nas propor&#231;&#245;es dos componentes intersticiais do mioc&#225;rdio, incluindo ac&#250;mulo de col&#225;geno na musculatura ventricular<sup>27,28</sup>. O est&#237;mulo para a RC ocorre por fatores mec&#226;nicos e bioqu&#237;micos que agem nos receptores, canais i&#244;nicos e nas integrinas presentes na membrana sarcolemal que, ativando sinalizadores bioqu&#237;micos citos&#243;licos, desencadeiam aumento da s&#237;ntese de prote&#237;nas e altera&#231;&#245;es na express&#227;o g&#234;nica<sup>2,12</sup>.</p>
    <p>A an&#225;lise da fun&#231;&#227;o sist&#243;lica do VE mostrou melhoria dos &#916;D endo e &#916;D meso no GEAo em rela&#231;&#227;o ao GC, que se deterioraram durante o processo de remodela&#231;&#227;o. A queda significativa do &#916;D endo no GEAo ocorreu a partir da 12&#170; semana; o decr&#233;scimo do &#916;D meso foi significante na 18&#170; (<xref ref-type="fig" rid="f1">Figuras 1</xref> e <xref ref-type="fig" rid="f2">2</xref>). Apesar desses &#237;ndices decrescerem ao longo do tempo, eles mantiveram-se superiores no GEAo, com exce&#231;&#227;o da 18&#170; semana, na qual a &#916;D meso igualou-se nos dois grupos. Embora o DC tenha aumentado nos dois grupos entre as 3&#170; e 18&#170; semanas, a eleva&#231;&#227;o foi menor no GEAo do que no GC somente na 18&#170; semana. Outro par&#226;metro que analisa a fun&#231;&#227;o de eje&#231;&#227;o do cora&#231;&#227;o, mas que leva em considera&#231;&#227;o o peso corporal, o InC, mostrou-se igual em ambos os grupos. A an&#225;lise dos diferentes &#237;ndices mostra que o mais sens&#237;vel para a detec&#231;&#227;o da disfun&#231;&#227;o sist&#243;lica foi o &#916;D endo, que detectou uma queda significativa na 12&#170; semana. Os outros dois &#237;ndices detectaram mais tardiamente, na 18&#170; semana.</p>
    <p>N&#227;o foram encontrados trabalhos que avaliassem a fun&#231;&#227;o sist&#243;lica do VE sequencialmente nos mesmos per&#237;odos analisados nesse experimento (3&#170;, 6&#170;, 12&#170; e 18&#170; semanas). Autores avaliando a fun&#231;&#227;o card&#237;aca de ratos com EAo p&#243;s 6&#170;, 12&#170; e 18&#170; semanas encontraram &#916;D endo supranormal na 6&#170; semana e &#916;D meso diminu&#237;do em todos os per&#237;odos em rela&#231;&#227;o ao GC. Enquanto a &#916;D endo decresceu, a &#916;D meso permaneceu est&#225;vel entre a 6&#170; e a 18&#170; semanas no GEAo<sup>8</sup>. Outro estudo observando a 6&#170;, 12&#170; e 21&#170; semanas encontrou queda na porcentagem de encurtamento na 21&#170; semana<sup>9</sup>.</p>
    <p>A melhoria da fun&#231;&#227;o sist&#243;lica no GEAo em rela&#231;&#227;o ao GC deve estar relacionada ao desenvolvimento da hipertrofia conc&#234;ntrica, normaliza&#231;&#227;o da tens&#227;o sist&#243;lica e manuten&#231;&#227;o dos limites fisiol&#243;gicos do consumo de oxig&#234;nio das fibras mioc&#225;rdicas<sup>2,16,19, 29</sup>. A perda progressiva da fun&#231;&#227;o sist&#243;lica pode estar relacionada: 1) ao remodelamento geom&#233;trico adverso da cavidade<sup>30,31</sup>; 2) a altera&#231;&#245;es da composi&#231;&#227;o do mioc&#225;rdio, como aumento da matriz extracelular e diminui&#231;&#227;o do n&#250;mero de mi&#243;citos, por necrose ou apoptose<sup>16,31</sup>; 3) ao comprometimento da contratilidade<sup>32</sup> ou 4) &#224; combina&#231;&#227;o destes fatores<sup>2,19,28</sup>.</p>
    <p>A avalia&#231;&#227;o do desempenho diast&#243;lico mostrou a ocorr&#234;ncia de disfun&#231;&#227;o precoce no GEAo em rela&#231;&#227;o ao GC. A partir da 3&#170; semana p&#243;s-indu&#231;&#227;o de EAo, no grupo com sobrecarga press&#243;rica ocorreu aumento da onda A, redu&#231;&#227;o da rela&#231;&#227;o E/A e do tempo de desacelera&#231;&#227;o da onda E (<xref ref-type="table" rid="t04">Tabela 4</xref> e <xref ref-type="fig" rid="f3">Figura 3</xref>). Esse dado mostra que a queda da fun&#231;&#227;o diast&#243;lica precede a sist&#243;lica, que ocorreu na 12&#170; semana.</p>
    <p>N&#227;o foram encontrados experimentos que observassem a fun&#231;&#227;o diast&#243;lica nos per&#237;odos avaliados nesta pesquisa. Litwin e cols.<sup>8</sup> encontraram no GEAo aumento da onda E nas 6&#170;, 12&#170; e 18&#170; semanas e diminui&#231;&#227;o da onda A na 18&#170; semana, quando comparado com o GC. A rela&#231;&#227;o E/A foi maior no GEAo do que no GC nas 12&#170; e 18&#170; semanas. Os autores concluem que a EAo promoveu uma disfun&#231;&#227;o diast&#243;lica do tipo restritiva a partir da 6&#170; semana. Ribeiro e cols.<sup>9</sup> verificaram aumento da rela&#231;&#227;o E/A a partir da 12&#170; semana em animais com EAo. A an&#225;lise comparativa entre os trabalhos da literatura e este experimento mostra que, embora em ambos a disfun&#231;&#227;o diast&#243;lica fosse um fato consistente e precoce, o comportamento da rela&#231;&#227;o E/A foi diferente. Enquanto nessa pesquisa a rela&#231;&#227;o E/A diminuiu, os outros autores encontraram aumento desta vari&#225;vel. Essa discrep&#226;ncia de resultados talvez se deva a dificuldades t&#233;cnicas na obten&#231;&#227;o de boas imagens para an&#225;lise do efeito Doppler e &#224; alta frequ&#234;ncia card&#237;aca desses animais, que funde as ondas E e A dificultando a mensura&#231;&#227;o da fun&#231;&#227;o diast&#243;lica<sup>33,34</sup>.</p>
    <p>Apesar da diferen&#231;a dos valores da rela&#231;&#227;o E/A com a literatura, o di&#226;metro do AE, isoladamente, mostrou-se aumentado a partir da 6&#170; semana e, quando normalizado pelo peso corporal, apresentou-se superior ao GC desde a 3&#170; semana; a rela&#231;&#227;o AE/AO indicou tend&#234;ncia a ser maior no GEAo a partir da 3&#170; semana (0,07&lt;p&gt;0,13). Portanto, a remodela&#231;&#227;o do AE na 3&#170; ou 6&#170; semana reflete disfun&#231;&#227;o diast&#243;lica de VE, desde que o desempenho sist&#243;lico mostrou-se melhorado no GEAo em rela&#231;&#227;o ao GC nestes dois momentos. Esses dados est&#227;o de acordo com outros autores<sup>4,11</sup> que constataram aumento dessa vari&#225;vel.</p>
    <p>A piora da fun&#231;&#227;o diast&#243;lica observada neste estudo pode estar relacionada a altera&#231;&#245;es das propriedades el&#225;sticas e a dist&#250;rbios no manejo do c&#225;lcio intracelular. Estudos experimentais t&#234;m associado o aumento da rigidez mioc&#225;rdica na EAo &#224; eleva&#231;&#227;o da deposi&#231;&#227;o das fibras col&#225;genas<sup>29,35</sup>. As altera&#231;&#245;es das prote&#237;nas relativas &#224; recaptura de c&#225;lcio intracelular, principalmente a bomba de c&#225;lcio do ret&#237;culo sarcoplasm&#225;tico, tamb&#233;m t&#234;m sido relacionadas com a queda do desempenho diast&#243;lico na EAo<sup>29</sup>.</p>
    <p>O estudo da fun&#231;&#227;o diast&#243;lica do VE &#233; de grande import&#226;ncia, tendo em vista que as altera&#231;&#245;es no enchimento desta cavidade podem anteceder a disfun&#231;&#227;o sist&#243;lica<sup>36</sup>. Atualmente, a forma mais vi&#225;vel e fact&#237;vel de avalia&#231;&#227;o da fun&#231;&#227;o diast&#243;lica &#233; a an&#225;lise das velocidades do fluxo transmitral, durante a fase inicial do enchimento diast&#243;lico do ventr&#237;culo esquerdo, representado pela onda E, e do enchimento ventricular durante a contra&#231;&#227;o atrial, expressa pela onda A. Da mesma forma, pode-se obter valores referentes &#224; rela&#231;&#227;o E/A, ao tempo de desacelera&#231;&#227;o da onda E e ao tempo de relaxamento isovolum&#233;trico (TRIV)<sup>25</sup>. A observa&#231;&#227;o de valores menores de onda E e da rela&#231;&#227;o E/A, quando comparados com o grupo controle, sugere a presen&#231;a de disfun&#231;&#227;o diast&#243;lica<sup>37</sup>. Outra forma de determina&#231;&#227;o da severidade da disfun&#231;&#227;o diast&#243;lica &#233; a avalia&#231;&#227;o do &#225;trio esquerdo pela ecocardiografia<sup>38</sup>. Durante a di&#225;stole ventricular, o AE &#233; exposto diretamente &#224;s press&#245;es intraventriculares por meio da valva mitral aberta. As eventuais eleva&#231;&#245;es de press&#245;es de enchimento ventricular acarretam aumento do volume e da press&#227;o atrial<sup>38</sup> e consequente remodelamento atrial.</p>
    <p>
      <bold>Conclus&#227;o</bold>
    </p>
    <p>Conclui-se, ap&#243;s o exame dos dados deste trabalho, que: 1) o ventr&#237;culo esquerdo dos ratos com EAo, durante o processo de remodela&#231;&#227;o, apresenta hipertrofia conc&#234;ntrica, disfun&#231;&#227;o diast&#243;lica precoce e melhoria da fun&#231;&#227;o sist&#243;lica, com posterior deteriora&#231;&#227;o do desempenho; 2) os &#237;ndices ecocardiogr&#225;ficos mais sens&#237;veis para a detec&#231;&#227;o da disfun&#231;&#227;o diast&#243;lica e sist&#243;lica s&#227;o, respectivamente, a rela&#231;&#227;o E/A e a porcentagem de encurtamento endoc&#225;rdico.</p>
    <p>
      <bold>Potencial Conflito de Interesses</bold>
    </p>
    <p>Declaro n&#227;o haver conflito de interesses pertinentes.</p>
    <p>
      <bold>Fontes de Financiamento</bold>
    </p>
    <p>O presente estudo n&#227;o teve fontes de financiamento externas.</p>
    <p>
      <bold>Vincula&#231;&#227;o Acad&#234;mica</bold>
    </p>
    <p>Este artigo &#233; parte de disserta&#231;&#227;o de Mestrado de Olga de Castro Mendes pelo Departamento de Cl&#237;nica M&#233;dica da Faculdade de Medicina de Botucatu.</p>
    <p>
      <fn id="back" fn-type="corresp">
        <p>Correspond&#234;ncia:</p>
        <p> Olga de Castro Mendes </p>
        <p> Faculdade de Medicina de Botucatu - UNESP </p>
        <p> Depto de Cl&#237;nica M&#233;dica - Rubi&#227;o J&#250;nior, S/N </p>
        <p> 18618-000 - Botucatu, SP, Brasil </p>
        <p> E-mail: </p>
        <p>
          <email xlink:href="ocmendes2003@yahoo.com.br">ocmendes2003@yahoo.com.br</email>
        </p>
      </fn>
    </p>
    <p>Artigo recebido em 05/11/08; revisado recebido em 23/03/09; aceito em 05/06/09</p>
  </body>
  <back>
    <ref-list>
      <ref id="B1">
        <mixed-citation>1. Cohn JN, Ferrarri    R, Sharpe N. Cardiac remodeling-concepts and clinical implications: a consensus    paper from an international forum on cardiac remodeling. J Am Coll Cardiol.    2000; 35: 562-82.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Cardiac remodeling-concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling</article-title>
          <source>J Am Coll Cardiol</source>
          <date>
            <year>2000</year>
          </date>
          <fpage>562</fpage>
          <lpage>82</lpage>
          <volume>35</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Cohn</surname>
              <given-names>JN</given-names>
            </name>
            <name>
              <surname>Ferrarri</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Sharpe</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B2">
        <mixed-citation>2. Cicogna AC,    Okoshi MP, Okoshi K. Hist&#243;ria natural da remodela&#231;&#227;o mioc&#225;rdica:    da agress&#227;o aos sintomas. Rev Soc Cardiol Estado de S&#227;o Paulo.    2000; 10: 8-16.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Hist&#243;ria natural da remodela&#231;&#227;o mioc&#225;rdica: da agress&#227;o aos sintomas</article-title>
          <source>Rev Soc Cardiol Estado de S&#227;o Paulo</source>
          <date>
            <year>2000</year>
          </date>
          <fpage>8</fpage>
          <lpage>16</lpage>
          <volume>10</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Cicogna</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Okoshi</surname>
              <given-names>MP</given-names>
            </name>
            <name>
              <surname>Okoshi</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B3">
        <mixed-citation>3. Olivetti G,    Cigola E, Maestri R, Lagrasta C, Corradi D, Quaini F. Recent advances in cardiac    hypertrophy. Cardiovasc Res. 2000; 45: 68-75.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Recent advances in cardiac hypertrophy</article-title>
          <source>Cardiovasc Res</source>
          <date>
            <year>2000</year>
          </date>
          <fpage>68</fpage>
          <lpage>75</lpage>
          <volume>45</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Olivetti</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Cigola</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Maestri</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Lagrasta</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Corradi</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Quaini</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B4">
        <mixed-citation>4. Gon&#231;alves    G, Zornoff LAM, Ribeiro HB, Okoshi MP, Cordaro FRS, Okoshi K, <italic>et al.</italic>    O bloqueio do sistema renina-angiotensina atenua a remodela&#231;&#227;o    card&#237;aca de ratos submetidos a estenose a&#243;rtica. Arq Bras Cardiol.    2005; 84: 304-8.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>O bloqueio do sistema renina-angiotensina atenua a remodela&#231;&#227;o card&#237;aca de ratos submetidos a estenose a&#243;rtica</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>304</fpage>
          <lpage>8</lpage>
          <volume>84</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Gon&#231;alves</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Zornoff</surname>
              <given-names>LAM</given-names>
            </name>
            <name>
              <surname>Ribeiro</surname>
              <given-names>HB</given-names>
            </name>
            <name>
              <surname>Okoshi</surname>
              <given-names>MP</given-names>
            </name>
            <name>
              <surname>Cordaro</surname>
              <given-names>FRS</given-names>
            </name>
            <name>
              <surname>Okoshi</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B5">
        <mixed-citation>5. Kaplan NM. Systemic    hypertension: mechanisms and diagnosis. In: Braunwald E, Zipes DP, Libby P.    eds. Heart disease: a textbook of cardiovascular medicine. Philadelphia: Saunders    Company; 2001 p. 941-71.</mixed-citation>
        <element-citation publication-type="book">
          <source>Heart disease: a textbook of cardiovascular medicine</source>
          <date>
            <year>2001</year>
          </date>
          <fpage>941</fpage>
          <lpage>71</lpage>
          <person-group person-group-type="author">
            <name>
              <surname>Kaplan</surname>
              <given-names>NM</given-names>
            </name>
            <name>
              <surname>Braunwald</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Zipes</surname>
              <given-names>DP</given-names>
            </name>
            <name>
              <surname>Libby</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B6">
        <mixed-citation>6. Weinberg EO,    Schoen FJ, George D, Kagaya Y, Douglas PS, Litwin SE, et al. Angiotensin-converting    enzyme inhibition prolongs survival and modifies the transition to heart failure    with pressure overload hypertrophy due ascending aortic stenosis. Circulation.    1994; 90: 1410-22.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Angiotensin-converting enzyme inhibition prolongs survival and modifies the transition to heart failure with pressure overload hypertrophy due ascending aortic stenosis</article-title>
          <source>Circulation</source>
          <date>
            <year>1994</year>
          </date>
          <fpage>1410</fpage>
          <lpage>22</lpage>
          <volume>90</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Weinberg</surname>
              <given-names>EO</given-names>
            </name>
            <name>
              <surname>Schoen</surname>
              <given-names>FJ</given-names>
            </name>
            <name>
              <surname>George</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Kagaya</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Douglas</surname>
              <given-names>PS</given-names>
            </name>
            <name>
              <surname>Litwin</surname>
              <given-names>SE</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B7">
        <mixed-citation>7. Bruckschlegel    G, Holmer SR, Jandeleit K, Grimm D, Muders F, Kromer EP, et al. Blockade of    the renin-angiotensin system in cardiac pressure-overload hypertrophy in rats.    Hypertension. 1995 ;25: 250-9.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Blockade of the renin-angiotensin system in cardiac pressure-overload hypertrophy in rats</article-title>
          <source>Hypertension</source>
          <date>
            <year>1995</year>
          </date>
          <fpage>250</fpage>
          <lpage>9</lpage>
          <volume>25</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Bruckschlegel</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Holmer</surname>
              <given-names>SR</given-names>
            </name>
            <name>
              <surname>Jandeleit</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Grimm</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Muders</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Kromer</surname>
              <given-names>EP</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B8">
        <mixed-citation>8. Litwin SE, Katz    SE, Weinberg EO, Lorell HB, Aurigemma GP, Douglas PS, et al. Serial echocardiographic-Doppler    assessment of left ventricular geometry and function in rats with pressure overload    hypertrophy chronic angiotensin-converting enzyme inhibition attenuates the    transition to heart failure. Circulation. 1995; 91: 2642-54.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Serial echocardiographic-Doppler assessment of left ventricular geometry and function in rats with pressure overload hypertrophy chronic angiotensin-converting enzyme inhibition attenuates the transition to heart failure</article-title>
          <source>Circulation</source>
          <date>
            <year>1995</year>
          </date>
          <fpage>2642</fpage>
          <lpage>54</lpage>
          <volume>91</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Litwin</surname>
              <given-names>SE</given-names>
            </name>
            <name>
              <surname>Katz</surname>
              <given-names>SE</given-names>
            </name>
            <name>
              <surname>Weinberg</surname>
              <given-names>EO</given-names>
            </name>
            <name>
              <surname>Lorell</surname>
              <given-names>HB</given-names>
            </name>
            <name>
              <surname>Aurigemma</surname>
              <given-names>GP</given-names>
            </name>
            <name>
              <surname>Douglas</surname>
              <given-names>PS</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B9">
        <mixed-citation>9. Ribeiro HB,    Okoshi K, Cicogna AC, Bregagnollo EA, Rodrigues MAM, Padovani CR, et al. Estudo    evolutivo da morfologia e fun&#231;&#227;o card&#237;aca em ratos submetidos    a estenose a&#243;rtica supravalvar. Arq Bras Cardiol. 2003; 81: 562-8.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Estudo evolutivo da morfologia e fun&#231;&#227;o card&#237;aca em ratos submetidos a estenose a&#243;rtica supravalvar</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>562</fpage>
          <lpage>8</lpage>
          <volume>81</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Ribeiro</surname>
              <given-names>HB</given-names>
            </name>
            <name>
              <surname>Okoshi</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Cicogna</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Bregagnollo</surname>
              <given-names>EA</given-names>
            </name>
            <name>
              <surname>Rodrigues</surname>
              <given-names>MAM</given-names>
            </name>
            <name>
              <surname>Padovani</surname>
              <given-names>CR</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B10">
        <mixed-citation>10. Moreira VO,    Castro AVB, Yaegaschi MY, Cicogna AC, Okoshi MP, Pereira CA, et al. Crit&#233;rios    ecocardiogr&#225;ficos para defini&#231;&#227;o de graus de disfun&#231;&#227;o    ventricular em ratos portadores de estenose a&#243;rtica. Arq Bras Cardiol.    2006; 86: 432-8.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Crit&#233;rios ecocardiogr&#225;ficos para defini&#231;&#227;o de graus de disfun&#231;&#227;o ventricular em ratos portadores de estenose a&#243;rtica</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>432</fpage>
          <lpage>8</lpage>
          <volume>86</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Moreira</surname>
              <given-names>VO</given-names>
            </name>
            <name>
              <surname>Castro</surname>
              <given-names>AVB</given-names>
            </name>
            <name>
              <surname>Yaegaschi</surname>
              <given-names>MY</given-names>
            </name>
            <name>
              <surname>Cicogna</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Okoshi</surname>
              <given-names>MP</given-names>
            </name>
            <name>
              <surname>Pereira</surname>
              <given-names>CA</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B11">
        <mixed-citation>11. Mestrinel MA.    Avalia&#231;&#227;o morfol&#243;gica, bioqu&#237;mica e funcional do    remodelamento card&#237;aco desencadeado por sobrecarga press&#243;rica    em ratos com e sem insufici&#234;ncia card&#237;aca congestiva. [disserta&#231;&#227;o].    Botucatu: Faculdade Medicina, Universidade Estadual Paulista; 2003.</mixed-citation>
        <element-citation publication-type="thesis">
          <source>Avalia&#231;&#227;o morfol&#243;gica, bioqu&#237;mica e funcional do remodelamento card&#237;aco desencadeado por sobrecarga press&#243;rica em ratos com e sem insufici&#234;ncia card&#237;aca congestiva</source>
          <date>
            <year>2003</year>
          </date>
          <person-group person-group-type="author">
            <name>
              <surname>Mestrinel</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B12">
        <mixed-citation>12. Okoshi K, Ribeiro    HB, Okoshi MP, Matsubara BB, Gon&#231;alves G, Barros R, et al. Improved systolic    ventricular function with normal myocardial mechanics in compensated cardiac    hypertrophy. Jpn Heart J. 2004; 45: 647-56.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Improved systolic ventricular function with normal myocardial mechanics in compensated cardiac hypertrophy</article-title>
          <source>Jpn Heart J</source>
          <date>
            <year>2004</year>
          </date>
          <fpage>647</fpage>
          <lpage>56</lpage>
          <volume>45</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Okoshi</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Ribeiro</surname>
              <given-names>HB</given-names>
            </name>
            <name>
              <surname>Okoshi</surname>
              <given-names>MP</given-names>
            </name>
            <name>
              <surname>Matsubara</surname>
              <given-names>BB</given-names>
            </name>
            <name>
              <surname>Gon&#231;alves</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Barros</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B13">
        <mixed-citation>13. Bregagnollo    EA, Okoshi K, Bregagnollo IF, Okoshi MP, Padovani CR, Cicogna AC. Effects of    the prolonged inhibition of the angiotensin-converting enzyme on the morphological    and functional characteristics of left ventricular hypertrophy in rats with    persistent pressure overload. Arq Bras Cardiol. 2005; 84: 225-32.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Effects of the prolonged inhibition of the angiotensin-converting enzyme on the morphological and functional characteristics of left ventricular hypertrophy in rats with persistent pressure overload</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>225</fpage>
          <lpage>32</lpage>
          <volume>84</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Bregagnollo</surname>
              <given-names>EA</given-names>
            </name>
            <name>
              <surname>Okoshi</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Bregagnollo</surname>
              <given-names>IF</given-names>
            </name>
            <name>
              <surname>Okoshi</surname>
              <given-names>MP</given-names>
            </name>
            <name>
              <surname>Padovani</surname>
              <given-names>CR</given-names>
            </name>
            <name>
              <surname>Cicogna</surname>
              <given-names>AC</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B14">
        <mixed-citation>14. Bregagnollo    EA, Zornoff LAM, Okoshi K, Sugizaki M, Mestrinel MA, Padovani CR, et al. Myocardial    contractile dysfunction contributes to the development of heart failure in rats    with aortic stenosis. Int J Cardiol. 2006; 113: 188-93.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Myocardial contractile dysfunction contributes to the development of heart failure in rats with aortic stenosis</article-title>
          <source>Int J Cardiol</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>188</fpage>
          <lpage>93</lpage>
          <volume>113</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Bregagnollo</surname>
              <given-names>EA</given-names>
            </name>
            <name>
              <surname>Zornoff</surname>
              <given-names>LAM</given-names>
            </name>
            <name>
              <surname>Okoshi</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Sugizaki</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Mestrinel</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Padovani</surname>
              <given-names>CR</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B15">
        <mixed-citation>15. Momken I, Kahapip    J, Bahi L, Badoual T, Hittinger l, Ventura-Clapier R, et al. Does angiotensin-converting    enzyme inhibition improve the energetic status cardiac and skeletal muscles    in heart failure induced by aortic stenosis in rats? J Mol Cell Cardiol. 2003;    33: 399-407.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Does angiotensin-converting enzyme inhibition improve the energetic status cardiac and skeletal muscles in heart failure induced by aortic stenosis in rats?</article-title>
          <source>J Mol Cell Cardiol</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>399</fpage>
          <lpage>407</lpage>
          <volume>33</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Momken</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Kahapip</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Bahi</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Badoual</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Hittinger</surname>
              <given-names>l</given-names>
            </name>
            <name>
              <surname>Ventura-Clapier</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B16">
        <mixed-citation>16. Boluyt MO,    O'Neil L, Meredith AL, Bing OHL, Brooks WW, Conrad CH, et al. Alterations in    cardiac gene expression during the transition from stable hypertrophy to heart    failure: marked upregulation of genes encoding extracellular matrix proteins.    Circ Res. 1994;75:23-32.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Alterations in cardiac gene expression during the transition from stable hypertrophy to heart failure: marked upregulation of genes encoding extracellular matrix proteins</article-title>
          <source>Circ Res</source>
          <date>
            <year>1994</year>
          </date>
          <fpage>23</fpage>
          <lpage>32</lpage>
          <volume>75</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Boluyt</surname>
              <given-names>MO</given-names>
            </name>
            <name>
              <surname>O'Neil</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Meredith</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Bing</surname>
              <given-names>OHL</given-names>
            </name>
            <name>
              <surname>Brooks</surname>
              <given-names>WW</given-names>
            </name>
            <name>
              <surname>Conrad</surname>
              <given-names>CH</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B17">
        <mixed-citation>17. Zar JH. Biostatistical    analysis. 4<sup>th</sup> ed. New York: Prentice-Hall; 1995.</mixed-citation>
        <element-citation publication-type="book">
          <source>Biostatistical analysis</source>
          <date>
            <year>1995</year>
          </date>
          <person-group person-group-type="author">
            <name>
              <surname>Zar</surname>
              <given-names>JH</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B18">
        <mixed-citation>18. Tanaka N, Dalton    N, Mao L, Rockman HA, Peterson KL, Gott-shall KR, et al. Transthoracic echocardiography    in models of cardiac disease in the mouse. Circulation. 1996; 94: 1109-17.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Transthoracic echocardiography in models of cardiac disease in the mouse</article-title>
          <source>Circulation</source>
          <date>
            <year>1996</year>
          </date>
          <fpage>1109</fpage>
          <lpage>17</lpage>
          <volume>94</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Tanaka</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Dalton</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Mao</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Rockman</surname>
              <given-names>HA</given-names>
            </name>
            <name>
              <surname>Peterson</surname>
              <given-names>KL</given-names>
            </name>
            <name>
              <surname>Gott-shall</surname>
              <given-names>KR</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B19">
        <mixed-citation>19. Cantor EJF,    Babick AP, Vasanji Z, Dhalla NS, Netticadan T. A comparative serial echocardiographic    analysis of cardiac structure and function in rats subjected to pressure or    volume overload. J Mol Cel Cardiol. 2005; 38: 777-86.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>A comparative serial echocardiographic analysis of cardiac structure and function in rats subjected to pressure or volume overload</article-title>
          <source>J Mol Cel Cardiol</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>777</fpage>
          <lpage>86</lpage>
          <volume>38</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Cantor</surname>
              <given-names>EJF</given-names>
            </name>
            <name>
              <surname>Babick</surname>
              <given-names>AP</given-names>
            </name>
            <name>
              <surname>Vasanji</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Dhalla</surname>
              <given-names>NS</given-names>
            </name>
            <name>
              <surname>Netticadan</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B20">
        <mixed-citation>20. Paiva SAR,    Zornoff LAM, Okoshi MP, Okoshi K, Matsubara LS, Matsubara BB, et al. Ventricular    remodeling induced by retinoic acid supplementation in adult rat. Am J Physiol    Heart Circ Physiol. 2003; 284: H2242-6.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Ventricular remodeling induced by retinoic acid supplementation in adult rat</article-title>
          <source>Am J Physiol Heart Circ Physiol</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>H2242</fpage>
          <lpage>6</lpage>
          <volume>284</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Paiva</surname>
              <given-names>SAR</given-names>
            </name>
            <name>
              <surname>Zornoff</surname>
              <given-names>LAM</given-names>
            </name>
            <name>
              <surname>Okoshi</surname>
              <given-names>MP</given-names>
            </name>
            <name>
              <surname>Okoshi</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Matsubara</surname>
              <given-names>LS</given-names>
            </name>
            <name>
              <surname>Matsubara</surname>
              <given-names>BB</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B21">
        <mixed-citation>21. Bregagnollo    EA, Mestrinel MA, Okoshi K, Carvalho FC, Bregagnollo IF, Padovani CR, et al.    Papel relativo da remodela&#231;&#227;o geom&#233;trica do ventr&#237;culo    esquerdo, morfol&#243;gica e funcional do mioc&#225;rdio na transi&#231;&#227;o    da hipertrofia compensada para a fal&#234;ncia card&#237;aca em ratos com    estenose a&#243;rtica supravalvar. Arq Bras Cardiol. 2007; 88: 225-33.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Papel relativo da remodela&#231;&#227;o geom&#233;trica do ventr&#237;culo esquerdo, morfol&#243;gica e funcional do mioc&#225;rdio na transi&#231;&#227;o da hipertrofia compensada para a fal&#234;ncia card&#237;aca em ratos com estenose a&#243;rtica supravalvar</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>225</fpage>
          <lpage>33</lpage>
          <volume>88</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Bregagnollo</surname>
              <given-names>EA</given-names>
            </name>
            <name>
              <surname>Mestrinel</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Okoshi</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Carvalho</surname>
              <given-names>FC</given-names>
            </name>
            <name>
              <surname>Bregagnollo</surname>
              <given-names>IF</given-names>
            </name>
            <name>
              <surname>Padovani</surname>
              <given-names>CR</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B22">
        <mixed-citation>22. Satoh S, Ueda    Y, Suematsu N, Oyama J, Kadokami T, Sugano M, et al. Beneficial effects of angiotensin-converting    enzyme inhibition on sarcoplasmatic reticulum function in the failing heart    of the Dahl rat. Circ J. 2003; 67: 705-11.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Beneficial effects of angiotensin-converting enzyme inhibition on sarcoplasmatic reticulum function in the failing heart of the Dahl rat</article-title>
          <source>Circ J</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>705</fpage>
          <lpage>11</lpage>
          <volume>67</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Satoh</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ueda</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Suematsu</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Oyama</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Kadokami</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Sugano</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B23">
        <mixed-citation>23. Ono K, Masuyama    T, Yamamoto K, Doi R, Sakata Y, Nishikawa N, et al. Echo Doppler assessment    of left ventricular function in rats with hypertensive hypertrophy. J Am Soc    Echocardiogr. 2002; 15: 109-17.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Echo Doppler assessment of left ventricular function in rats with hypertensive hypertrophy</article-title>
          <source>J Am Soc Echocardiogr</source>
          <date>
            <year>2002</year>
          </date>
          <fpage>109</fpage>
          <lpage>17</lpage>
          <volume>15</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Ono</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Masuyama</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Yamamoto</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Doi</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Sakata</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Nishikawa</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B24">
        <mixed-citation>24. Saha DC, Saha    AC, Malik G, Astiz ME, Rackow EC. Comparison of cardiovascular effects of tiletamine-zolazepam,    pentobarbital, and ketamine-xylazine in male rats. J Am Assoc Lab Anim Sci.    2007; 46: 74-80.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Comparison of cardiovascular effects of tiletamine-zolazepam, pentobarbital, and ketamine-xylazine in male rats</article-title>
          <source>J Am Assoc Lab Anim Sci</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>74</fpage>
          <lpage>80</lpage>
          <volume>46</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Saha</surname>
              <given-names>DC</given-names>
            </name>
            <name>
              <surname>Saha</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Malik</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Astiz</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Rackow</surname>
              <given-names>EC</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B25">
        <mixed-citation>25. Yang X, Liu    Y, Rhaleb N, Kurihara N, Kim HE, Carretero, OA. Echocardiographic assessment    of cardiac function in conscious and anesthetized mice. Am J Physiol Heart Cir    Physiol. 1999; 277: 1967-74.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Echocardiographic assessment of cardiac function in conscious and anesthetized mice</article-title>
          <source>Am J Physiol Heart Cir Physiol</source>
          <date>
            <year>1999</year>
          </date>
          <fpage>1967</fpage>
          <lpage>74</lpage>
          <volume>277</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Yang</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Rhaleb</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Kurihara</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>HE</given-names>
            </name>
            <name>
              <surname>Carretero</surname>
              <given-names>OA</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B26">
        <mixed-citation>26. Rakusan K.    Left ventricular hypertrophy alterations in myocite number, size, shape and    struture. In: Scheridan DJ. (ed.) Left ventricular hypertrophy. London: Churchill    Livingstone; 1998. p. 23-8.</mixed-citation>
        <element-citation publication-type="book">
          <source>Left ventricular hypertrophy</source>
          <date>
            <year>1998</year>
          </date>
          <fpage>23</fpage>
          <lpage>8</lpage>
          <person-group person-group-type="author">
            <name>
              <surname>Rakusan</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Scheridan</surname>
              <given-names>DJ</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B27">
        <mixed-citation>27. Buccino RA,    Haris S, Spann JF. Response of myocardial tissue to development of experimental    hypertrophy. Am J Physiol. 1969; 216: 425-8.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Response of myocardial tissue to development of experimental hypertrophy</article-title>
          <source>Am J Physiol</source>
          <date>
            <year>1969</year>
          </date>
          <fpage>425</fpage>
          <lpage>8</lpage>
          <volume>216</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Buccino</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Haris</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Spann</surname>
              <given-names>JF</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B28">
        <mixed-citation>28. Weber KT, Pick    R, Jalil JE, Janicki JS, Carroll EP. Patterns of myocardial fibrosis. J Mol    Cell Cardiol. 1989; 21: 121-31.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Patterns of myocardial fibrosis</article-title>
          <source>J Mol Cell Cardiol</source>
          <date>
            <year>1989</year>
          </date>
          <fpage>121</fpage>
          <lpage>31</lpage>
          <volume>21</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Weber</surname>
              <given-names>KT</given-names>
            </name>
            <name>
              <surname>Pick</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Jalil</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Janicki</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Carroll</surname>
              <given-names>EP</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B29">
        <mixed-citation>29. Boluyt MO,    Robinson KG, Meredith AL, Sem S, Lakatta EG, Crow MT, et al. Heart failure after    long-term supravalvar aortic constriction in rats. Am J Hypertens. 2005; 18:    202-12.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Heart failure after long-term supravalvar aortic constriction in rats</article-title>
          <source>Am J Hypertens</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>202</fpage>
          <lpage>12</lpage>
          <volume>18</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Boluyt</surname>
              <given-names>MO</given-names>
            </name>
            <name>
              <surname>Robinson</surname>
              <given-names>KG</given-names>
            </name>
            <name>
              <surname>Meredith</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Sem</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Lakatta</surname>
              <given-names>EG</given-names>
            </name>
            <name>
              <surname>Crow</surname>
              <given-names>MT</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B30">
        <mixed-citation>30. Norton GR,    Woodiwiss AJ, Gaash WH, Mela T, Chung ES, Aurigemma GP, et al. Heart failure    in pressure overload hypertrophy: the relative roles of ventricular remodeling    and myocardial dysfunction. J Am Coll Cardiol. 2002; 39: 664-71.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Heart failure in pressure overload hypertrophy: the relative roles of ventricular remodeling and myocardial dysfunction</article-title>
          <source>J Am Coll Cardiol</source>
          <date>
            <year>2002</year>
          </date>
          <fpage>664</fpage>
          <lpage>71</lpage>
          <volume>39</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Norton</surname>
              <given-names>GR</given-names>
            </name>
            <name>
              <surname>Woodiwiss</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Gaash</surname>
              <given-names>WH</given-names>
            </name>
            <name>
              <surname>Mela</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Chung</surname>
              <given-names>ES</given-names>
            </name>
            <name>
              <surname>Aurigemma</surname>
              <given-names>GP</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B31">
        <mixed-citation>31. Mann DL. Mechanism    and models in heart failure: a combinatorial approach. Circulation. 1999; 100:    999-1008.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Mechanism and models in heart failure: a combinatorial approach</article-title>
          <source>Circulation</source>
          <date>
            <year>1999</year>
          </date>
          <fpage>999</fpage>
          <lpage>1008</lpage>
          <volume>100</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Mann</surname>
              <given-names>DL</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B32">
        <mixed-citation>32. Houser SR,    Margulies KB. Is depressed myocite contractile centrally involved in heart failure?    Circ Res. 2003; 92: 350-8.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Is depressed myocite contractile centrally involved in heart failure?</article-title>
          <source>Circ Res</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>350</fpage>
          <lpage>8</lpage>
          <volume>92</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Houser</surname>
              <given-names>SR</given-names>
            </name>
            <name>
              <surname>Margulies</surname>
              <given-names>KB</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B33">
        <mixed-citation>33. Pritchett AM,    Jacobsen SJ, Mahoney DW, Rodeheffer RJ, Bailey KR, Redfield MM. Left atrial    volume as an index of left atrial size: a population-based study. J Am Coll    Cardiol. 2003; 41: 1036-43.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Left atrial volume as an index of left atrial size: a population-based study</article-title>
          <source>J Am Coll Cardiol</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>1036</fpage>
          <lpage>43</lpage>
          <volume>41</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Pritchett</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Jacobsen</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Mahoney</surname>
              <given-names>DW</given-names>
            </name>
            <name>
              <surname>Rodeheffer</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Bailey</surname>
              <given-names>KR</given-names>
            </name>
            <name>
              <surname>Redfield</surname>
              <given-names>MM</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B34">
        <mixed-citation>34. Gelape CL,    Sanches MD, Torres RM, Couto CA, Paix&#227;o PC, Melo JRC. An&#225;lise    ecocardiogr&#225;fica da fun&#231;&#227;o diast&#243;lica do ventr&#237;culo    esquerdo ap&#243;s infarto do mioc&#225;rdio em ratos. Rev Bras Cir Cardiovasc.    2005; 20: 63-8.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>An&#225;lise ecocardiogr&#225;fica da fun&#231;&#227;o diast&#243;lica do ventr&#237;culo esquerdo ap&#243;s infarto do mioc&#225;rdio em ratos</article-title>
          <source>Rev Bras Cir Cardiovasc</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>63</fpage>
          <lpage>8</lpage>
          <volume>20</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Gelape</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Sanches</surname>
              <given-names>MD</given-names>
            </name>
            <name>
              <surname>Torres</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Couto</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Paix&#227;o</surname>
              <given-names>PC</given-names>
            </name>
            <name>
              <surname>Melo</surname>
              <given-names>JRC</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B35">
        <mixed-citation>35. Jalil JE, Christian    WD, Janick JS, Pick R, Shroff SG, Weber KT. Fibrillar collagen and myocardial    stiffness in the intact hypertrophied rat left ventricle. Circ Res.1989; 64:    1041-50.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Fibrillar collagen and myocardial stiffness in the intact hypertrophied rat left ventricle</article-title>
          <source>Circ Res</source>
          <date>
            <year>1989</year>
          </date>
          <fpage>1041</fpage>
          <lpage>50</lpage>
          <volume>64</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Jalil</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Christian</surname>
              <given-names>WD</given-names>
            </name>
            <name>
              <surname>Janick</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Pick</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Shroff</surname>
              <given-names>SG</given-names>
            </name>
            <name>
              <surname>Weber</surname>
              <given-names>KT</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B36">
        <mixed-citation>36. Jessup M, Brozena    S. Heart failure. N Engl J Med. 2003; 348: 2007-18.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Heart failure</article-title>
          <source>N Engl J Med</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>2007</fpage>
          <lpage>18</lpage>
          <volume>348</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Jessup</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Brozena</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B37">
        <mixed-citation>37. Mady C, Salemi    VMC, Ianni BM, Ramires FJA, Arteaga E. Capacidade funcional m&#225;xima, fra&#231;&#227;o    de eje&#231;&#227;o e classe funcional na cardiomiopatia chag&#225;sica:    existe rela&#231;&#227;o entre estes &#237;ndices? Arq Bras Cardiol. 2005;    84: 152-5.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Capacidade funcional m&#225;xima, fra&#231;&#227;o de eje&#231;&#227;o e classe funcional na cardiomiopatia chag&#225;sica: existe rela&#231;&#227;o entre estes &#237;ndices?</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>152</fpage>
          <lpage>5</lpage>
          <volume>84</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Mady</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Salemi</surname>
              <given-names>VMC</given-names>
            </name>
            <name>
              <surname>Ianni</surname>
              <given-names>BM</given-names>
            </name>
            <name>
              <surname>Ramires</surname>
              <given-names>FJA</given-names>
            </name>
            <name>
              <surname>Arteaga</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B38">
        <mixed-citation>38. Sousa ACS.    Volume atrial esquerdo como &#237;ndice da fun&#231;&#227;o diast&#243;lica.    Arq Bras Cardiol. 2006; 87: e27-e33.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Volume atrial esquerdo como &#237;ndice da fun&#231;&#227;o diast&#243;lica</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>e27</fpage>
          <lpage>e33</lpage>
          <volume>87</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Sousa</surname>
              <given-names>ACS</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <sub-article article-type="translation" id="TRen" xml:lang="en">
    <front-stub>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Articles</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title xml:lang="en">Cardiac remodeling: serial analysis and indexes for early detection of ventricular dysfunction</article-title>
      </title-group>
      <abstract xml:lang="en">
        <p>BACKGROUND: Supravalvar aortic stenosis (SVAS) is used to study overload-induced cardiac remodeling (CR). In this model, neither CR behavior since beginning stage nor the best parameters to identify ventricular dysfunction are clearly stated. Objective: 1) Characterizing, early and evolutively, morphological and functional modifications during CR in rats with SVAS and 2) identifying the most sensitive index for detecting the moment when the diastolic and systolic dysfunction first appeared in the left ventricle (LV). METHODS: Wistar Rats were divided into two groups - control (CG, n=13) and SVAS (SVASG, n=24) - and studied in post-surgical 3rd, 6th, 12th and 18th weeks. Hearts were analyzed by means of an echocardiogram (ECHO). RESULTS: By the end of the experiment, ratios between the LV, right ventricle and atria and the final body weight were increased in the SVASG. The ECHO showed that the left atrium underwent significant remodeling from the 6th on. The percent of endocardial shortening underwent significant drop as of the 12nd week and the percent of, as of the 18th week, in the SVASG. The ratio between E- wave and A-wave (E/A) was higher in CG compared to the SVASG in all events analyzed. CONCLUSIONS: During the remodeling process, the left ventricle of rats with SVAS presented concentric hypertrophy, early diastolic dysfunction and improvement of systolic function, with posterior performance deterioration. Besides this, the study found out the most sensitive echocardiographic indexes for detecting systolic and diastolic dysfunction are, respectively, the ratio E/A and the percent of endocardial shortening.</p>
      </abstract>
      <kwd-group xml:lang="en">
        <kwd>Aortic Stenosis</kwd>
        <kwd>Supravalvular</kwd>
        <kwd>Ventricular Remodeling</kwd>
        <kwd>Echocardiography</kwd>
        <kwd>Rats</kwd>
        <kwd>Ventricular Dysfunction</kwd>
      </kwd-group>
    </front-stub>
    <body>
      <p>
        <bold>ORIGINAL ARTICLE</bold>
      </p>
      <p>
        <fn id="top-body2">
          <label>
            <bold>Cardiac remodeling: serial analysis and indexes for early detection of ventricular dysfunction</bold>
          </label>
          <p>
            <bold>Olga de Castro Mendes<sup>I, II</sup>; Dijon Henrique S. de Campos<sup>I</sup>; Ricardo Luiz Damatto<sup>I</sup>; M&#225;rio Mateus Sugizaki<sup>I, II</sup>; Carlos Roberto Padovani<sup>I</sup>; Katashi Okoshi<sup>I</sup>; Ant&#244;nio Carlos Cicogna<sup>I</sup></bold>
          </p>
        </fn>
      </p>
      <p><sup>I</sup>Departamento de Cl&#237;nica M&#233;dica - Faculdade de Medicina FMB - UNESP, Botucatu, SP, Brasil</p>
      <p><sup>II</sup>Faculdades Integradas de Bauru, Bauru, SP, Brasil</p>
      <p>Mailing address</p>
      <p>
        <bold>ABSTRACT</bold>
      </p>
      <p><bold>BACKGROUND:</bold> Supravalvar aortic stenosis (SVAS) is used to study overload-induced cardiac remodeling (CR). In this model, neither CR behavior since beginning stage nor the best parameters to identify ventricular dysfunction are clearly stated.</p>
      <p><bold>OBJECTIVE:</bold> 1) Characterizing, early and evolutively, morphological and functional modifications during CR in rats with SVAS and 2) identifying the most sensitive index for detecting the moment when the diastolic and systolic dysfunction first appeared in the left ventricle (LV).</p>
      <p><bold>METHODS: </bold> Wistar Rats were divided into two groups - control (CG, n=13) and SVAS (SVASG, n=24) - and studied in post-surgical 3<sup>rd</sup>, 6<sup>th</sup>, 12<sup>th</sup> and 18<sup>th</sup> weeks. Hearts were analyzed by means of an echocardiogram (ECHO).</p>
      <p><bold>RESULTS: </bold> By the end of the experiment, ratios between the LV, right ventricle and atria and the final body weight were increased in the SVASG. The ECHO showed that the left atrium underwent significant remodeling from the 6<sup>th</sup> on. The percent of endocardial shortening underwent significant drop as of the 12nd week and the percent of, as of the 18th week, in the SVASG. The ratio between E- wave and A-wave (E/A) was higher in CG compared to the SVASG in all events analyzed.</p>
      <p><bold>CONCLUSIONS: </bold> During the remodeling process, the left ventricle of rats with SVAS presented concentric hypertrophy, early diastolic dysfunction and improvement of systolic function, with posterior performance deterioration. Besides this, the study found out the most sensitive echocardiographic indexes for detecting systolic and diastolic dysfunction are, respectively, the ratio E/A and the percent of endocardial shortening.</p>
      <p><bold>Key-Words:</bold> Aortic Stenosis, Supravalvular; Ventricular Remodeling; Echocardiography; Rats; Ventricular Dysfunction / Risk Assessment.</p>
      <p>
        <bold>Introduction</bold>
      </p>
      <p>Cardiac remodeling (CR) refers to an alteration in gene expression in response to an aggression, resulting in molecular changes, cellular changes and myocardial interstitial alterations, expressed in variations of the heart size, shape and function<sup>1</sup>. This is also a mechanism in adaptation to hemodynamic overload, allowing the heart to keep its functions in view of load increase<sup>2-4</sup>. This is deemed as a risk factor for development of ventricular dysfunction and heart failure (HF)<sup>5</sup>.</p>
      <p>Several experimental models have been proposed for the study of CR due to pressure overload, such as supravalvar aortic stenosis (SVAS) in rats<sup>6-8</sup>. When young animals are subject to aortic constriction, pressure overload is low at the beginning, being increased proportionally with their growth. SVAS advantages are: gradual development of CR, associated in short term to the improvement of systolic function; absence of severe lesions in myocardial anatomy; and low maintenance cost<sup>9</sup>. Around the 20<sup>th</sup> week of SVAS, deterioration of systolic performance and HF<sup>10-13</sup> begin. This model is partially similar to SVAS in men<sup>11</sup>.</p>
      <p>Experiments in our lab with rats with SVAS assessed morphological and functional cardiac aspects, by means of echocardiogram (ECHO), in different periods of CR, finding out supranormal systolic function in 6<sup>th</sup> or 8<sup>th</sup> week<sup>4,9,12</sup>, diastolic dysfunction as of the 12nd week<sup>9</sup> and deterioration of systolic performance in the 21<sup>st</sup> week. This last group of animals also had signs of heart failure<sup>9</sup>. Some authors, using hemodynamic evaluation, verified increase in left ventricular end-diastolic pressure after the 6<sup>th</sup> week - in contrast, evaluation of diastolic function by means of ECHO has been found inaltered<sup>13</sup>. Litwin et al<sup>8</sup> assessed rats with SVAS by means of ECHO during 6<sup>th</sup>, 12<sup>th</sup> and 18<sup>th</sup> weeks, and observed diastolic dysfunction as of the 6<sup>th</sup> week and deterioration of systolic performance in the 18<sup>th</sup> week.</p>
      <p>Analysis of mentioned studies has shows controversial results and absence of evaluation in an earlier post-induction of SVAS. The study aimed at characterizing, early and evolutively, morphological and functional modifications during CR in rats with SVAS targeting on identifying the most sensitive index for detecting the moment when left ventricular diastolic and systolic dysfunction first appeared.</p>
      <p>
        <bold>Method</bold>
      </p>
      <p>Experimental procedures were approved by the Ethics Committee on Animal Research of the Medicine School of Botucatu - UNESP, on October 19<sup>th</sup>, 2005, under no. 506/2005.</p>
      <p>
        <bold>Animals and experimental protocol</bold>
      </p>
      <p>37 Wistar male young rats were used, obtained from the Animal Room of the Medical Clinic Department of Medicine School of UNESP - Botucatu, State of S&#227;o Paulo, which were divided into two groups: control group (CG, n=13) and supravalvar aortic stenosis group (SVASG , n=24). The SVASG was subject to surgery with implantation of a clip in aorta artery for induction of SVA. The CG was subject to the same surgery, albeit with no implantation of clip. Five animals were kept in each box, at ambient temperature of 23&#176;C, with 12-hour light cycles, fed with standard animal food Purina<sup>&#174;</sup> and ad libitum water.</p>
      <p>Animals were studied in 3<sup>rd</sup>, 6<sup>th</sup>, 12<sup>th</sup> and 18<sup>th</sup> post-surgical weeks. These periods are suitable to observing morphological and functional alterations in rats with SVA and precede appearance of HF, which takes place around the 20<sup>th</sup> week<sup>9,10,13</sup>.</p>
      <p>By the end of the experiment, HF signs were sought, and the presence of tachypnea was considered an exclusion criterion when associated to one of the following signs: oedema, ascites, pleuro-pericardial effusion, thrombus in left atrium (LA) and right ventricular (RV) hypertrophy<sup>14</sup>.</p>
      <p>By the end of the 18<sup>th</sup> week, animals were anesthetized with sodium pentobarbital, (50 mg/kg), intraperitoneal, and beheaded. Then, a cardiac morphological analysis was performed.</p>
      <p>
        <bold>Induction of supravalvar aortic stenosis</bold>
      </p>
      <p>The SVAS was inducted according to method used in our lab<sup>4,12</sup>. Animals, weighing from 70 to 90 g, after anesthetized with ketamine chloride (60 mg/kg) and xylazine chloride (10 mg/kg), intraperitoneal, were subject to median thoracotomy. The ascending aorta was dissected and a silver clip, with 0.6 mm of internal diameter, was placed approximately 3 mm apart from the aortic root. The CG's animals were subject to the same surgery, albeit with no implantation of clip.</p>
      <p>
        <bold>Echocardiographic Assessment</bold>
      </p>
      <p>Heart's function and structure were analyzed by means of ECHO according to methodology used in our lab<sup>4,9,10,14</sup>. Animals were anesthetized with ketamine chloride (50 mg/kg) and xylazine chloride (1 mg/kg), intraperitoneal. A M-mode echocardiograph (Philips<sup>&#174;</sup>, HDI 5000 model) was used, equipped with a 12 MHz electronic transducer. The following LV morphological parameters were assessed: left ventricular diastolic diameter (LVDD) and left ventricular systolic diameter (LVSD), posterior wall diastolic thickness and posterior wall systolic thickness (PWDT and PWST); interventricular septum diastolic thickness and interventricular septum systolic thickness (IVSDT and IVSST); and left ventricular mass (LV MASS). The LV mass index (LVMI) was determined by normalizing LV mass in view of the body weight (BW). The LV relative wall thickness (LVRWT) was obtained using the formula (2x PWDT)/LVDD.</p>
      <p>The LV systolic function was determined by the percent of endocardial shortening ("D endo) and the midwall fractional shortening ("D mid), and the speed of shortening of the LV posterior wall (LVPW), cardiac output (CO) and cardiac index (CI). The "D mid was calculated using the formula ({[(LVDD + &#189; PWDT + &#189; IVSDT) - (LVSD + &#189; PWST + &#189; IVSST)]/(LVDD + &#189; PWDT + &#189; IVSDT )}); the LVPW was determined by the maximum tangent of the posterior wall systolic movement; the CO using the formula [(LVDD &#179; - LVSD&#179;) x heart rate; and the CI by means of the ratio between the CO and the BW .</p>
      <p>The diastolic function was assessed by E-waves and A, ratio between E-waves and A-wave (E/A), E-wave deceleration times (WDT) and the LV isovolumetric relaxation time (LV-IVRT)<sup>15,16</sup>.</p>
      <p>
        <bold>Morphological analysis</bold>
      </p>
      <p>Morphological variables to characterize animals were: final body weights (FBW) of LV, RV, atria (AT's) and the ratios LV/FBW, RV/FBW and AT's/FBW.</p>
      <p>
        <bold>Statistical analysis</bold>
      </p>
      <p>Morphological parameters were analyzed using the Student's t-test, when the variable has shown adherence to the normal probability distribution, and using the Mann-Whitney test, when this characteristic was absent. For group comparisons in evolutive process, the analysis of variance (ANOVA) method of recurrent measures in two independent groups, supplemented by Bonferroni multiple comparison procedure. For the A-wave variable, the statistical procedure considered the non-parametric technique. In their turn, other variables were analyzed using the parametric technique<sup>17</sup>. For all tests, 5% (p&lt;0.05) was the significance level fixed. Graphs show average results and standard error. Statistical calculations where made using statistical analysis software SigmaStat 3.5 for Windows version (Copyright<sup>&#169;</sup> 2006, Systat Software Inc.).</p>
      <p>
        <bold>Results</bold>
      </p>
      <p>By the end of the experiment, out of 24 SVASG's rats, 10 died (41.6%) and 2 developed HF (14.28%), and were excluded from the study. There were 2 deaths in the CG (15.4%). Thus, studied groups consisted of 11 animals in the CG and 12 in the SVASG. Mortality found is similar to rates found by other authors, who found rates ranging from 30 to 49%<sup>5,7,12,13</sup>.</p>
      <p>
        <bold>General characteristics</bold>
      </p>
      <p>Initial weight of rats did not change: 82&#177;5 g for the CG and 85&#177;5 g for the SVASG. Body weight evolutive analysis has shown that the CG has had higher rate than the SVASG only in the 12<sup>th</sup> week, with a tendency to being superior in the 18<sup>th</sup> week (p=0.07). General characteristics of animals by the end of the experiment are shown in <xref ref-type="table" rid="t1-body2">Table 1</xref>. The LV's and AT's weights and the ratios LV/FBW, RV/FBW and AT's/FBW have increased in SVASG.</p>
      <table-wrap id="t1-body2">
        <graphic xlink:href="1678-4170-abc-94-01-0062-00011-gt01-en.jpg"/></table-wrap>
      <p>
        <bold>Echocardiographic assessment of the heart's structural parameters</bold>
      </p>
      <p><xref ref-type="table" rid="en_11t02-body2">Table 2</xref> shows the heart's sequential structural assessment by ECHO. The LVMI has decreased in the CG's animals in 12<sup>th</sup> and 18<sup>th</sup> weeks, compared to the 3<sup>rd</sup> week, and has not changed in the SVASG. The highest index has been found in the SVASG vis-&#224;-vis the CG as of the 6<sup>th</sup> week, although, already in the 3<sup>rd</sup> week, there were tendency to be increased in the SVASG (p=0.058). The LVDD was equal in the 6<sup>th</sup>, 12<sup>th</sup> and 18<sup>th</sup> weeks, higher to the diameter found in the 3<sup>rd</sup> week in both groups. This variable was smaller in the SVASG when compared to the CG. The ratio LVDD/BW in the CG and in the SVASG was higher during the 3<sup>rd</sup> week versus the other weeks. 12<sup>th</sup> and 18<sup>th</sup> weeks had a ratio inferior to the 6<sup>th</sup> week's one. No difference was found between the groups. The LVSD was higher in the 6<sup>th</sup> and 12<sup>th</sup> weeks versus the 3<sup>rd</sup> in the CG. In its turn, the LVSD increased during 6<sup>th</sup>, 12<sup>th</sup> and 18<sup>th</sup> weeks in the SVASG compared to the 3<sup>rd</sup> week. The 18<sup>th</sup> week was different from the 6<sup>th</sup> week. The LVSD was smaller in the SVASG compared to the CG.</p>
      <p content-type="asset">
        <table-wrap id="en_11t02-body2">
          <graphic xlink:href="1678-4170-abc-94-01-0062-00011-gt02-en.jpg"/></table-wrap>
      </p>
      <p>The PWDT and IVSDT did not present changes in the CG over the experiment's period; they changed in moments 12 and 18 in relation to moments 3 and 6 in the SVASG's animals. These parameters were higher in the SVASG versus the CG at all times. The LVRWT did not change in the CG. The 18<sup>th</sup> week was different from the 6<sup>th</sup> week in the SVASG. This variable was higher in the SVASG compared to the CG in all weeks. There was no change of LA in the CG, although there was tendency to be higher in the 12<sup>th</sup> (p=0.075) and 18th (p=0.063) weeks versus the 3<sup>rd</sup> week. In the SVASG, the LA was higher as of week 6, and there was no posterior change. The LA presented higher values in the SVASG than in the CG as of the 6<sup>th</sup> week. The ration LA/BW was smaller in the 6<sup>th</sup>, 12<sup>th</sup> and 18<sup>th</sup> weeks - smaller than in week 6 in both groups when compared to the 3<sup>rd</sup>, and to the 12<sup>th</sup> and 18<sup>th</sup> weeks. This ratio was higher in the SVASG than in the CG in all periods. The AO in the CG over the 6<sup>th</sup> and 12<sup>th</sup> weeks was different from the 3<sup>rd</sup> week. The 18<sup>th</sup> week was different from all others. In the SVASG, the 6<sup>th</sup>, 12<sup>th</sup> and 18<sup>th</sup> weeks were higher than the 3<sup>rd</sup> week. This variable was smaller in the SVASG versus the CG over the 18<sup>th</sup> week. There was no variation in the LA/AO ratio between the different moments in both groups. Although the SVASG had presented increase of the LA/AO ratio vis-&#224;-vis the CG, there was tendency of the SVASG's values to the higher than the GC's ones (0.07&gt;p&lt;0.13) only in the 18<sup>th</sup> week. AO's absolute and relative data have shown that this chamber underwent significant remodeling as of the 6<sup>th</sup> week.</p>
      <p>
        <bold>Echocardiographic assessment of the left ventricle systolic and diastolic functions</bold>
      </p>
      <p><xref ref-type="table" rid="en_11t03-body2">Tables 3</xref> and <xref ref-type="table" rid="en_11t04-body2">4</xref> describe, respectively, the CF and the parameters for the LV systolic and diastolic function assessment. Differences in the CF between groups and moments have not been found. There was no difference in "D endo and "D mid in view of the time in the CG. In the SVASG, the "D endo of the 12<sup>th</sup> week was smaller than the 3<sup>rd</sup> week's one and higher than the 18<sup>th</sup> week's one, smaller that the 3<sup>rd</sup> and 6<sup>th</sup> weeks. The "D mid in the SVASG was smaller in the 18<sup>th</sup> week versus 3<sup>rd</sup> and 6<sup>th</sup>. The "D endo and "D mid were higher in the SVASG than in the CG at all times, except for the 18<sup>th</sup> week, in which the "D mid was equal in both groups (<xref ref-type="table" rid="en_11t03-body2">Table 3</xref>). In <xref ref-type="fig" rid="f1-body2">Figures 1</xref> and <xref ref-type="fig" rid="f2-body2">2</xref>, it may be seen that, while the "D endo and "D mid did not change in the CG, there was drop in these two indexes in the SVASG during the process evolution, becoming significant after the 12<sup>th</sup> week in the "D endo, and in the "D mid during the 18<sup>th</sup> week.</p>
      <p content-type="asset">
        <table-wrap id="en_11t03-body2">
          <graphic xlink:href="1678-4170-abc-94-01-0062-00011-gt03-en.jpg"/></table-wrap>
      </p>
      <p content-type="asset">
        <table-wrap id="en_11t04-body2">
          <graphic xlink:href="1678-4170-abc-94-01-0062-00011-gt04-en.jpg"/></table-wrap>
      </p>
      <fig id="f1-body2">
        <graphic xlink:href="1678-4170-abc-94-01-0062-00011-gf01-en.jpg"/></fig>
      <fig id="f2-body2">
        <graphic xlink:href="1678-4170-abc-94-01-0062-00011-gf02-en.jpg"/></fig>
      <p>The LVPW, when assessed between groups, has been found significantly higher in the 18th week versus 3<sup>rd</sup> and 6<sup>th</sup> weeks in the CG, and unaltered in the SVASG. There was reduction of LVPW in the SVASG compared to the CG during the 18<sup>th</sup> week. CO increased in the 12th and 18th weeks versus the 3<sup>rd</sup> one in the CG, with tendency to be higher in the 6<sup>th</sup> week versus the 3<sup>rd</sup> one (p=0.083). In the SVASG, the 6th, 12th and 18th weeks were higher than the 3rd week. There was difference of CO between the groups only in the 18<sup>th</sup> week, and this was smaller in the SVASG. The CI decreased in the 12<sup>th</sup> and 18<sup>th</sup> weeks in the CG versus the previous weeks. In the SVASG, the 18<sup>th</sup> week had smaller values than the 3<sup>rd</sup> and 6<sup>th</sup> weeks' ones. There was tendency of the 12<sup>th</sup> week to have smaller values that the 6<sup>th</sup> week's ones (p=0.069). No difference was found between the groups (<xref ref-type="table" rid="en_11t03-body2">Table 3</xref>).</p>
      <p>In the CG and SVASG (<xref ref-type="table" rid="en_11t04-body2">Table 4</xref>), E-wave and A-wave have not presented alterations in different periods of the assessment. While the E-wave was equal in group comparison, the A-wave was higher in the SVASG than in the CG at all periods. The E/A ration presented decrease in the CG during the 18<sup>th</sup> week versus the 3<sup>rd</sup> one, with tendency to be smaller in the 18<sup>th</sup> week versus the 6<sup>th</sup> (p=0.067) and the 12<sup>th</sup> (p=0.095) weeks. In the SVASG, difference between moments was not found, with tendency to difference between the 3<sup>rd</sup> and 18<sup>th</sup> weeks (p=0.10). The E/A ratio has shown to be higher in the CG in different moments assessed (<xref ref-type="table" rid="en_11t04-body2">Table 4</xref> and <xref ref-type="fig" rid="f3-body2">Figure 3</xref>). The LV-IVRT was similar in the CG at all times. The SVASG was higher in the 18th week versus the 3<sup>rd</sup> and 6<sup>th</sup> weeks. No difference was found between the groups. The WDT was similar in the CG. In the SVASG, there was tendency to difference between the 6<sup>th</sup> and 18<sup>th</sup> weeks (pp=0.058) and between the 12<sup>th</sup> and 18<sup>th</sup> weeks (p=0.063). The WDT was smaller in the SVASG during moments 3, 12 and 18 versus the CG.</p>
      <fig id="f3-body2">
        <graphic xlink:href="1678-4170-abc-94-01-0062-00011-gf03-en.jpg"/></fig>
      <p>
        <bold>Discussion</bold>
      </p>
      <p>Cardiac morphology and function were assessed in this study during the remodeling process in rats subject to SVAS. Remodeling occurs as a response to this aggression and may cause ventricular dysfunction. The main criterion for diagnosis of this functional alteration in experimental studies have been the LV end diastolic pressure, assessed using hemodynamic method<sup>18</sup>. However, determining this pressure requires an invasive process, a fact that jeopardizes long-term studies. Besides this, the LV's characterization may bring damages to aortic valve or affect the cardiac performance<sup>19</sup>.</p>
      <p>The ECHO represents an alternative for the ventricular function study and may provide important information on the rodent's cardiac performance<sup>19</sup>. It allows to assess the cardiac morphology and function<sup>8,19-21</sup>, the evolution of the ventricular dysfunction caused by different types of aggression<sup>22</sup> and the effects of different interventions<sup>13,23</sup>. It is a versatile, safe, painless, non-invasive method, which is also important to <italic>in vivo</italic> serial analysis<sup>24</sup>.</p>
      <p>Echocardiographic results in this study show significant structural alterations of the LV during the remodeling evolution process<sup>25</sup>. The LVMI decreased in the CG as of the 12<sup>th</sup> week due to the increase of the rats' body weight. The LVMI kept stable in the SVASG. Insomuch as this parameter is not directly proportional to the body weight, the normalized values increase or decrease if there is weight loss or gain, respectively. Several parameters which indicate hypertrophy, such as PWDT, IVSDT and LVRWT, have altered as of the 3<sup>rd</sup> week. The LVMI changed after the 6th week. The LVRWT analysis indicated that the SVAS caused an early concentric hypertrophy of the LV, kept until the end of the experiment. The left ventricular remodeling using ECHO was ascertained by cardiac structural assessment after rats were sacrificed (<xref ref-type="table" rid="t1-body2">Table 1</xref>).</p>
      <p>In addition to the left ventricle hypertrophy, results show that the SVASG's rats, in the event of being sacrificed, presented a hypertrophy of the right ventricle, assessed by means of ratio RV/BW. In spite of the heart failure diagnosis has been made by associating two clinical/morphological signs in this experiment, as described previously, the single ascertainment of increase in this ration does not mean the SVASG's rats suffered from heart failure. However, atrium weight increase and the increase of this weight with the body weight have shown that the rats presented left ventricular dysfunction when they were being sacrificed.</p>
      <p>The LV structural data, determined by ECHO or post-sacrifice, are similar to data of a number of studies which detected ventricular hypertrophy in different stages of CR post-induction of SVAS<sup>4,6,8,11,12</sup>. Values observed in the LVSD different from those of the area's bibliography, which has not found alteration of this variable in the SVASG after the 6<sup>th</sup> week of SVAS induction<sup>4,19</sup>.</p>
      <p>Development of left ventricular hypertrophy was an adaptative response to the intraventricular pressure elevation with the SVAS, as the increase of the wall thickness and the reduction of the cavity's size may normalize the parietal stress and, consequently, the ventricular function. The concentric hypertrophy is a result of the increase of the myocytes' diameter with little or no change in the cellular size<sup>26</sup>. Concomitantly, there are changes in the proportions of myocardial interstitial components, including accumulation of collagen in ventricular musculature<sup>27,28</sup>. Stimulus to CR happens due to mechanical and biochemical factors that act on receptors, ion channels and integrins present in sarcolemal membrane which, by activating biochemical citosolic signalizers, trigger increase of protein synthesis and alterations in gene expression<sup>2,12</sup>.</p>
      <p>The analysis of LV systolic function showed improvement of "D endo and "D mid in the SVASG versus the CG, which underwent deterioration during remodeling process. Significant drop of "D endo in the SVASG took place as of the 12<sup>th</sup> week. In its turn, decrease of "D mid was significant in the 18<sup>th</sup> week (<xref ref-type="fig" rid="f1-body2">Figures 1</xref> and <xref ref-type="fig" rid="f2-body2">2</xref>). In spite of these indexes decrease along the time, they kept higher in the SVASG, except for the 18<sup>th</sup> week, in which "D mid was equal for both groups. Although CO has been increased in these two groups between 3<sup>rd</sup> and 18<sup>th</sup> weeks, the elevation was smaller in the SVASG than in the CG only in the 18<sup>th</sup> week. Another parameter which helps to analyze the heart's ejection fraction, taking into account the body weight for that purpose, obtaining CI scenario similar in both groups. Analysis of different indexes show that the most sensitive for detecting systolic dysfunction was the "D endo, which detected a significant drop during the 12<sup>th</sup> week. Other indicators were able to detect it only later on, during the 18<sup>th</sup> week.</p>
      <p>Studies assessing the LV systolic function sequentially, over the same periods of this experiment, (3<sup>rd</sup>, 6<sup>th</sup>, 12<sup>th</sup> and 18<sup>th</sup> weeks) could not be found. Authors analyzing cardiac function in rats with SVAS after 6<sup>th</sup>, 12<sup>th</sup> and 18<sup>th</sup> weeks have found supranormal "D endo during the 6<sup>th</sup> week and smaller "D mid in all periods in relation to the CG. While the "D endo decreased, the "D mid remained stable between the 6<sup>th</sup> and the 18<sup>th</sup> weeks in the SVASG<sup>8</sup>. Other study focusing the 6<sup>th</sup>, 12<sup>th</sup> and 21<sup>st</sup> weeks has found drop in the percent of shortening during the 21<sup>st</sup> week<sup>9</sup>.</p>
      <p>Improvement of systolic function in the SVASG versus the CG must be linked to the development of concentric hypertrophy, normalization of systolic tension and maintenance of physiological limits of oxygen consumption of myocardial fibers<sup>2,16,19,29</sup>. Progressive loss of systolic function may be connected with: 1) adverse geometrical remodeling of the cavity<sup>30,31</sup>; 2) alterations in the composition of the heart muscle, with increase of the extracellular matrix and decrease in the number of myocytes, due to necrosis or apoptosis<sup>16,31</sup>; 3) compromising of the capacity to contract<sup>32</sup> or 4) the combination of these factors<sup>2,19,28</sup>.</p>
      <p>Assessment of the diastolic performance showed the occurrence of early dysfunction in the SVASG compared to the CG. As of the 3rd week post-induction of the SVAS, there was increase of A-wave, reduction of E/A ratio and of E-wave deceleration time in the group with pressure overload (<xref ref-type="table" rid="en_11t04-body2">Table 4</xref> and <xref ref-type="fig" rid="f3-body2">Figure 3</xref>). This piece of data shows that the drop in diastolic function precedes the drop in systolic function, which took place in the 12<sup>th</sup> week.</p>
      <p>Experiments observing the diastolic function in the same periods of this research were not found. Litwin et al<sup>8</sup> found out increase of E-wave in 6<sup>th</sup>, 12<sup>th</sup> and 18<sup>th</sup> weeks and decrease of A-wave in the 18<sup>th</sup> week in the SVASG, compared to the CG. E/A ratio was higher in the SVASG than in the CG in 12<sup>th</sup> and 18<sup>th</sup> weeks. Authors conclude that the SVAS caused a restrictive diastolic dysfunction as of the 6<sup>th</sup> week. Ribeiro et al<sup>9</sup> verified increase of the E/A ratio as of the 12<sup>th</sup> week in animals with SVAS. Comparative analysis between reference studies and this experiment shows that, although diastolic dysfunction was a consistent and early factor for both, the behavior of the E/A ratio was different. While the E/A ratio decreased in this research, other authors found increase of this variable. Perhaps, this difference in results may be attributable to technical difficulties while obtaining good images for analysis of the Doppler effect and to the high heart rate of these animals, which tend to mix E and A waves, rendering diastolic function measurement difficult<sup>33,34</sup>.</p>
      <p>In spite of the differences in the E/A ratio compared to the reference studies, the LA diameter alone has shown increase as of the 6<sup>th</sup> week and, when normalized by body weight, has been found higher than the CG's LA diameter since the 3<sup>rd</sup> week; the LA/AO ratio indicated tendency to be higher in the SVASG as of the 3<sup>rd</sup> week (0.07&lt;p&gt;0.13). Thus, remodeling of the LA during the 3<sup>rd</sup> or 6<sup>th</sup> week is a result of the LV's diastolic dysfunction, as the systolic performance has shown improvement in the SVASG compared to the CG in these two moments. These data is in accordance with the authors' findings<sup>4,11</sup> which ascertained increase in this variable.</p>
      <p>The worsening of the diastolic function found in this study may be connected with alteration of elastic properties and disturbances in intracellular calcium handling. Experimental studies have associated the increase of the myocardial rigidity in the SVAS with the increase of collagen fiber deposition<sup>29,35</sup>. Alterations in proteins linked to intracellular calcium recovery, mainly the sarcoplasmic reticulum calcium pump, have also been related to the drop in diastolic performance in presence of SVAS<sup>29</sup>.</p>
      <p>The study of the LV's diastolic function is rather relevant as the alterations in filling of this cavity may precede systolic dysfunction<sup>36</sup>. Currently, the most viable and feasible way to assess diastolic function is by analyzing transmitral flow speed during the initial stage of left ventricle's diastolic filling, represented by E-wave, and of the ventricular filling during atrial contraction, expressed by A-wave. Values related to the E/A ration, the E-wave deceleration time and to the isovolumetric relaxation time (LV-IVRT)<sup>25</sup> may be found in a similar way. Upon observation of smaller E-wave and E/A ratio values, compared to the control group, there is suggestion of presence of diastolic dysfunction<sup>37</sup>. Another way to determine the severity of diastolic dysfunction is by assessing the left atrium by means of echocardiograph<sup>38</sup>. During ventricular diastole, the LA is directly exposed to intraventricular pressures through open mitral valve. Occasional rise in ventricular filling pressures may cause increase in volume and in atrial pressure<sup>38</sup> and consequent atrial remodeling.</p>
      <p>
        <bold>Conclusion</bold>
      </p>
      <p>After data found is examined, this study concludes that: 1) the left ventricle of rats with the SVAS, during remodeling process, presents concentric hypertrophy, early diastolic dysfunction and improvement of systolic function, with posterior performance deterioration; 2) the most sensitive echocardiographic indexes for detecting systolic and diastolic dysfunction are, respectively, the E/A ratio and the percent of endocardial shortening.</p>
      <p>
        <bold>Potential Conflict of Interest</bold>
      </p>
      <p>No potential conflict of interest relevant to this article was reported.</p>
      <p>
        <bold>Sources of Funding</bold>
      </p>
      <p>There were no external funding sources for this study.</p>
      <p>
        <bold>Study Association</bold>
      </p>
      <p>This article is part of the thesis of master submitted by Olga de Castro Mendes, from Departamento de Cl&#237;nica M&#233;dica da Faculdade de Medicina de Botucatu.</p>
      <p>
        <bold>References</bold>
      </p>
    </body>
  </sub-article>
  <sub-article article-type="translation" id="TRes" xml:lang="es">
    <front-stub>
      <article-categories/>
      <title-group>
        <article-title xml:lang="es">Remodelaci&#243;n cardiaca: an&#225;lisis seriado e &#237;ndices de detecci&#243;n precoz de disfunci&#243;n ventricular</article-title>
      </title-group>
      <abstract xml:lang="es">
        <p>FUNDAMENTO: La estenosis a&#243;rtica supravalvular (EAo) se utiliza para el estudio de la remodelaci&#243;n cardiaca (RC) por sobrecarga de presi&#243;n. En este modelo, no est&#225;n claramente establecidos el comportamiento del RC desde la fase inicial, ni los mejores par&#225;metros para la identificaci&#243;n de la disfunci&#243;n ventricular. OBJETIVO: 1) Caracterizar, precoz y evolutivamente, las modificaciones morfofuncionales durante el RC en ratones con EAo, y 2) identificar el &#237;ndice m&#225;s sensible para detecci&#243;n del momento de la aparici&#243;n de la disfunci&#243;n diast&#243;lica y sist&#243;lica del ventr&#237;culo izquierdo (VI). M&#201;TODOS: Ratones Wistar se dividieron en dos grupos - control (GC, n=13) y EAo (GEAo, n=24) - y estudiados en las 3&#170;, 6&#170;, 12&#170; y 18&#170; semanas post cirug&#237;a. Los corazones se analizaron por medio de ecocardiograma (ECO). RESULTADOS: Al final del experimento, las relaciones del VI, del ventr&#237;culo derecho y de los atrios con el peso corporal final fueron aumentadas en el GEAo. El ECO mostr&#243; que el atrio izquierdo sufri&#243; una remodelaci&#243;n significativa a partir de la 6&#170; semana. En el GEAo, el porcentaje de acortamiento endoc&#225;rdico present&#243; disminuci&#243;n significativa a partir de la 12&#170; semana y el porcentaje de acortamiento mesoc&#225;rdico, en la 18&#170; semana. La relaci&#243;n onda E y onda A (E/A) fue superior en el GC en comparaci&#243;n al GEAo en todos los momentos analizados. CONCLUSI&#211;N: El ventr&#237;culo izquierdo de los ratones con EAo, durante el proceso de remodelaci&#243;n, present&#243; hipertrofia conc&#233;ntrica, disfunci&#243;n diast&#243;lica precoz y mejora de la funci&#243;n sist&#243;lica, con posterior deterioro del desempe&#241;o. Adem&#225;s de ello, se constat&#243; que los &#237;ndices ecocardiogr&#225;ficos m&#225;s sensibles para la detecci&#243;n de la disfunci&#243;n diast&#243;lica y sist&#243;lica son, respectivamente, la relaci&#243;n E/A y el porcentaje de acortamiento endoc&#225;rdico.</p>
      </abstract>
      <kwd-group xml:lang="es">
        <kwd>Estenosis a&#243;rtica supravalvular</kwd>
        <kwd>remodelaci&#243;n ventricular</kwd>
        <kwd>ecocardiograma</kwd>
        <kwd>ratones</kwd>
        <kwd>disfunci&#243;n ventricular</kwd>
      </kwd-group>
    </front-stub>
    <body>
      <p>
        <bold>ART&#205;CULO ORIGINAL</bold>
      </p>
      <p>
        <fn id="top-body3">
          <label>
            <bold>Remodelaci&#243;n cardiaca: an&#225;lisis seriado e &#237;ndices de detecci&#243;n precoz de disfunci&#243;n ventricular</bold>
          </label>
          <p>
            <bold>Olga de Castro Mendes<sup>I, II</sup>; Dijon Henrique S. de Campos<sup>I</sup>; Ricardo Luiz Damatto<sup>I</sup>; M&#225;rio Mateus Sugizaki<sup>I, II</sup>; Carlos Roberto Padovani<sup>I</sup>; Katashi Okoshi<sup>I</sup>; Ant&#244;nio Carlos Cicogna<sup>I</sup></bold>
          </p>
        </fn>
      </p>
      <p><sup>I</sup>Departamento de Cl&#237;nica M&#233;dica - Faculdade de Medicina FMB - UNESP, Botucatu, SP - Brasil</p>
      <p><sup>II</sup>Faculdades Integradas de Bauru, Bauru, SP - Brasil</p>
      <p>Correspondencia</p>
      <p>
        <bold>RESUMEN</bold>
      </p>
      <p><bold>FUNDAMENTO: </bold> La estenosis a&#243;rtica supravalvular (EAo) se utiliza para el estudio de la remodelaci&#243;n cardiaca (RC) por sobrecarga de presi&#243;n. En este modelo, no est&#225;n claramente establecidos el comportamiento del RC desde la fase inicial, ni los mejores par&#225;metros para la identificaci&#243;n de la disfunci&#243;n ventricular.</p>
      <p><bold>OBJETIVO: </bold> 1) Caracterizar, precoz y evolutivamente, las modificaciones morfofuncionales durante el RC en ratones con EAo, y 2) identificar el &#237;ndice m&#225;s sensible para detecci&#243;n del momento de la aparici&#243;n de la disfunci&#243;n diast&#243;lica y sist&#243;lica del ventr&#237;culo izquierdo (VI).</p>
      <p><bold>M&#201;TODOS: </bold> Ratones Wistar se dividieron en dos grupos - control (GC, n=13) y EAo (GEAo, n=24) - y estudiados en las 3&#170;, 6&#170;, 12&#170; y 18&#170; semanas post cirug&#237;a. Los corazones se analizaron por medio de ecocardiograma (ECO).</p>
      <p><bold>RESULTADOS: </bold> Al final del experimento, las relaciones del VI, del ventr&#237;culo derecho y de los atrios con el peso corporal final fueron aumentadas en el GEAo. El ECO mostr&#243; que el atrio izquierdo sufri&#243; una remodelaci&#243;n significativa a partir de la 6&#170; semana. En el GEAo, el porcentaje de acortamiento endoc&#225;rdico present&#243; disminuci&#243;n significativa a partir de la 12&#170; semana y el porcentaje de acortamiento mesoc&#225;rdico, en la 18&#170; semana. La relaci&#243;n onda E y onda A (E/A) fue superior en el GC en comparaci&#243;n al GEAo en todos los momentos analizados.</p>
      <p><bold>CONCLUSI&#211;N: </bold> El ventr&#237;culo izquierdo de los ratones con EAo, durante el proceso de remodelaci&#243;n, present&#243; hipertrofia conc&#233;ntrica, disfunci&#243;n diast&#243;lica precoz y mejora de la funci&#243;n sist&#243;lica, con posterior deterioro del desempe&#241;o. Adem&#225;s de ello, se constat&#243; que los &#237;ndices ecocardiogr&#225;ficos m&#225;s sensibles para la detecci&#243;n de la disfunci&#243;n diast&#243;lica y sist&#243;lica son, respectivamente, la relaci&#243;n E/A y el porcentaje de acortamiento endoc&#225;rdico. (Arq Bras Cardiol 2010; 94(1) : 59-66)</p>
      <p><bold>Palabras clave: </bold> Estenosis a&#243;rtica supravalvular, remodelaci&#243;n ventricular, ecocardiograma, ratones, disfunci&#243;n ventricular/medici&#243;n de riesgo.</p>
      <p>
        <bold>Introducci&#243;n</bold>
      </p>
      <p>La remodelaci&#243;n cardiaca (RC) es una alteraci&#243;n en la expresi&#243;n g&#233;nica en respuesta a una agresi&#243;n, resultando en cambios moleculares, celulares e intersticiales mioc&#225;rdicos, y que se expresa por variaciones en el tama&#241;o, forma y funci&#243;n del coraz&#243;n<sup>1</sup>. Tambi&#233;n es un mecanismo adaptativo a la sobrecarga hemodin&#225;mica, permitiendo al coraz&#243;n mantener sus funciones en vigencia de aumento de carga<sup>2-4</sup>. Se considera factor de riesgo para el desarrollo de disfunci&#243;n ventricular e insuficiencia card&#237;aca (IC)<sup>5</sup>.</p>
      <p>Se han propuesto diversos modelos experimentales para el estudio del RC por sobrecarga pres&#243;rica, como la estenosis a&#243;rtica supravalvular (EAo) en ratones<sup>6-8</sup>. Cuando la constricci&#243;n a&#243;rtica se realiza en animales j&#243;venes, la sobrecarga pres&#243;rica inicial es leve, acentu&#225;ndose con el crecimiento. Las ventajas de la EAo son: El desarrollo gradual de RC asociado, a corto plazo, a la mejora de la funci&#243;n sist&#243;lica; ausencia de severas lesiones anat&#243;micas mioc&#225;rdicas; y bajo costo de mantenimiento<sup>9</sup>. Alrededor de la 20&#170; semana de EAo ocurre deterioro del desempe&#241;o sist&#243;lico e IC<sup>10-13</sup>. Este modelo se asemeja parcialmente a la EAo en el hombre<sup>11</sup>.</p>
      <p>Experimentos en nuestro laboratorio, realizados en ratones con EAo, evaluaron aspectos morfofuncionales card&#237;acos, por medio de ecocardiograma (ECO), en diferentes per&#237;odos de RC, constatando funci&#243;n sist&#243;lica supranormal en la 6&#170; u 8&#170; semana<sup>4,9,12</sup>, disfunci&#243;n diast&#243;lica a partir de la 12&#170; semana<sup>9</sup> y deterioro del desempe&#241;o sist&#243;lico en la 21&#170; semana, siendo incluidos en esta &#250;ltima tanda animales con se&#241;ales de insuficiencia card&#237;aca<sup>9</sup>. Algunos autores, utilizando evaluaci&#243;n hemodin&#225;mica, verificaron aumento en la presi&#243;n diast&#243;lica final del ventr&#237;culo izquierdo (VI) despu&#233;s de la 6&#170; semana - en contraste, la evaluaci&#243;n de la funci&#243;n diast&#243;lica por ECO se mostr&#243; inalterada<sup>13</sup>. Litwin et al<sup>8</sup> evaluando, por medio de ECO, ratones con EAo en las 6&#170;, 12&#170; y 18&#170; semanas, observaron disfunci&#243;n diast&#243;lica a partir de la 6&#170; semana y deterioro en el desempe&#241;o sist&#243;lico en la 18&#170; semana.</p>
      <p>El an&#225;lisis de los trabajos citados muestra controversias de resultados y ausencia de una evaluaci&#243;n en un per&#237;odo m&#225;s inicial post inducci&#243;n de EAo. El objetivo del trabajo fue caracterizar, precoz y evolutivamente, las modificaciones morfofuncionales durante el RC en ratones con EAo, buscando identificar el &#237;ndice m&#225;s sensible para detecci&#243;n del momento de la aparici&#243;n de la disfunci&#243;n diast&#243;lica y sist&#243;lica del ventr&#237;culo izquierdo.</p>
      <p>
        <bold>M&#233;todos</bold>
      </p>
      <p>Los procedimientos experimentales fueron aprobados por el Comit&#233; de &#201;tica en Investigaci&#243;n Animal de la Facultad de Medicina de Botucatu-UNESP, el 19/10/2005, con el n&#186; 506/2005.</p>
      <p>
        <bold>Animales y protocolo experimental</bold>
      </p>
      <p>Se utilizaron 37 ratones Wistar, machos y j&#243;venes, provenientes del Bioterio del Departamento de Cl&#237;nica M&#233;dica de la Facultad de Medicina de la UNESP - Botucatu/SP, los cuales se dividieron en dos grupos: control (GC, n=13) y estenosis a&#243;rtica supravalvular (GEAo, n=24). El GEAo fue sometido a la cirug&#237;a con implantaci&#243;n de un clip en la arteria aorta para la inducci&#243;n de la EAo. El GC fue sometido a la misma cirug&#237;a, pero sin la colocaci&#243;n del clip. Se mantuvieron cinco animales por caja, a temperatura ambiente de 23&#176;C, con ciclos de luminosidad de 12 horas, alimentados con raci&#243;n est&#225;ndar Purina<sup>&#174;</sup> y agua <italic>ad libitum</italic>.</p>
      <p>Los animales se estudiaron en las 3&#170;, 6&#170;, 12&#170; y 18&#170; semanas despu&#233;s de la cirug&#237;a. Estos per&#237;odos son adecuados para la observaci&#243;n de alteraciones morfofuncionales en ratones con EAo y anteceden la instalaci&#243;n de la IC, que ocurre en torno de la 20&#170; semana<sup>9,10,13</sup>.</p>
      <p>Al final del experimento, se busc&#243; identificar se&#241;ales de IC, consider&#225;ndose criterio de exclusi&#243;n la presencia de taquipnea asociada a una de las siguientes se&#241;ales: edema, ascitis, derrame pleuroperic&#225;rdico, trombo en atrio izquierdo (AI) e hipertrofia del ventr&#237;culo derecho (VD)<sup>14</sup>.</p>
      <p>Al final de la 18&#170; semana, los animales fueron anestesiados con pentobarbital s&#243;dico intraperitoneal (50 mg/kg) y decapitados, realiz&#225;ndose entonces el an&#225;lisis morfol&#243;gico card&#237;aco.</p>
      <p>
        <bold>Inducci&#243;n de estenosis a&#243;rtica supravalvular</bold>
      </p>
      <p>La EAo fue inducida de acuerdo con el m&#233;todo utilizado en nuestro laboratoio<sup>4,12</sup>. Los animales, pesando de 70 a 90 g, despu&#233;s de la anestesia con clorhidrato de ketamina (60 mg/kg) y clorhidrato de xylazina (10 mg/kg) intraperitoneal, fueron sometidos a toracotom&#237;a mediana. La aorta ascendente fue disecada y un clip de plata, con 0,6 mm de di&#225;metro interno, colocado aproximadamente a 3 mm de su ra&#237;z. Los animales del GC fueron sometidos a la misma cirug&#237;a, pero sin la colocaci&#243;n del clip.</p>
      <p>
        <bold>Evaluaci&#243;n ecocargiogr&#225;fica</bold>
      </p>
      <p>La funci&#243;n y la estructura del coraz&#243;n fueron analizadas por ECO de acuerdo con la metodolog&#237;a utilizada en nuestro laboratorio<sup>4,9,10,14</sup>. Los animales fueron anestesiados con clorhidrato de ketamina (50 mg/kg) y clorhidrato de xylazina (1 mg/kg) por v&#237;a intraperitoneal. Fue utilizado un ecocardi&#243;grafo (Philips<sup>&#174;</sup>, modelo HDI 5000) modo-M, equipado con transductor electr&#243;nico de 12 MHz. Se evaluaron los siguientes par&#225;metros morfol&#243;gicos del VI: Di&#225;metros diast&#243;lico (DDVI) y sist&#243;lico (DSVI), espesores diast&#243;licos y sist&#243;licos de la pared posterior (EDPP y ESPP) y del septo interventricular (EDSIV y ESSIV) y masa (MASA VI). El &#237;ndice de masa del VI (IMVI) fue determinado normalizando la masa del VI por el peso corporal (PC). El espesor relativo de la pared del VI (ERelVI) se obtuvo por la f&#243;rmula (2xEDPP)/DDVI.</p>
      <p>La funci&#243;n sist&#243;lica del VI fue determinada por el porcentaje de acortamiento endoc&#225;rdico (&#916;D endo) y mesoc&#225;rdico (&#916;D meso), velocidad de acortamiento de la pared posterior del VI (VAPP), d&#233;bito card&#237;aco (DC) e &#237;ndice card&#237;aco (InC). La &#916;D meso fue calculada por la f&#243;rmula ({[(DDVI + &#189; EDPP + &#189; EDSIV) - (DSVI + &#189; ESPP + &#189; ESSIV)] / (DDVI + &#189; EDPP + &#189; EDSIV)}); la VEPP se determin&#243; por la tangente m&#225;xima del movimiento sist&#243;lico de la pared posterior; el DC por la f&#243;rmula [(DDVI&#179; - DSVI&#179;) x frecuencia card&#237;aca]; y el InC por la relaci&#243;n del DC con el PC.</p>
      <p>La funci&#243;n diast&#243;lica se evalu&#243; por las ondas E y A, relaci&#243;n entre ondas E y onda A (E/A), tiempos de desaceleraci&#243;n de la onda E (TDE) y de relajaci&#243;n isovolum&#233;trica del VI (TRIV)<sup>15,16</sup>.</p>
      <p>
        <bold>An&#225;lisis morfol&#243;gico</bold>
      </p>
      <p>Las variables morfol&#243;gicas para caracterizar los animales fueron: pesos corporales finales (PCF) del VI, del VD, de los atrios (ATs) y las relaciones VI/PCF, VD/PCF y ATs/PCF.</p>
      <p>
        <bold>An&#225;lisis estad&#237;stico</bold>
      </p>
      <p>Los par&#225;metros morfol&#243;gicos fueron analizados por el test t de Student, cuando la variable presentaba distribuci&#243;n normal de probabilidad, y por el test de Mann-Whitney, cuando esta caracter&#237;stica estaba ausente. Para comparaciones de los grupos en el proceso evolutivo, se utiliz&#243; el m&#233;todo de an&#225;lisis de varianza (ANOVA) de medidas repetidas en dos grupos independientes, complementado por el procedimiento de comparaci&#243;n m&#250;ltiple de Bonferroni. Para la variable onda A, el procedimiento estad&#237;stico consider&#243; la t&#233;cnica no param&#233;trica; para las otras variables, se consider&#243; la t&#233;cnica param&#233;trica<sup>17</sup>. En todas las pruebas, se fij&#243; en el 5% (p&lt;0,05) el nivel de significancia. Los gr&#225;ficos presentan los resultados en promedio y error est&#225;ndar. Los c&#225;lculos estad&#237;sticos se realizaron con el auxilio del paquete estad&#237;stico SigmaStat 3.5 <italic>for Windows version</italic> (Copyright<sup>&#169;</sup> 2006, Systat Software Inc.).</p>
      <p>
        <bold>Resultados</bold>
      </p>
      <p>Al final del experimento, de los 24 ratones del GEAo murieron 10 (41,6%) y 2 presentaron IC (14,28%), siendo excluidos del estudio. En el GC ocurrieron 2 muertes (15,4%). As&#237;, los grupos estudiados estaban constituidos de 11 en el GC y 12 en el GEAo. La mortalidad observada est&#225; de acuerdo con otros autores que constataron tasas variando de 30 a 49%<sup>5,7,12,13</sup>.</p>
      <p>
        <bold>Caracter&#237;sticas generales</bold>
      </p>
      <p>El peso inicial de los ratos no diferi&#243;, siendo 82&#177;5 g para el GC y 85&#177;5 g para el GEAo. El an&#225;lisis evolutivo del peso corporal mostr&#243; que el GC fue mayor que el GEAo s&#243;lo en la 12&#170; semana, con tendencia a la superioridad en la 18&#170; semana (p=0,07). Las caracter&#237;sticas generales de los animales al final del experimento est&#225;n expuestas en la <xref ref-type="table" rid="t1-body3">Tabla 1</xref>. El peso del VI y de los ATs y las relaciones VI/PCF, VD/PCF y A/PCF fueron aumentados en el GEAo.</p>
      <table-wrap id="t1-body3">
        <graphic xlink:href="1678-4170-abc-94-01-0062-00011-gt01-es.jpg"/></table-wrap>
      <p>
        <bold>Evaluaci&#243;n ecocardiogr&#225;fica de los par&#225;metros estructurales del coraz&#243;n</bold>
      </p>
      <p>La <xref ref-type="table" rid="es_11t02-body3">Tabla 2</xref> presenta la evaluaci&#243;n secuencial estructural de coraz&#243;n por ECO. El IMVI disminuy&#243; en los animales del GC en las 12&#170; y 18&#170; semanas, en comparaci&#243;n a la 3&#170; semana, y no se alter&#243; en el GEAo. El &#237;ndice fue mayor en el GEAo con relaci&#243;n al GC a partir de la 6&#170; semana, aunque en la 3&#170; semana ya hab&#237;a una tendencia estar aumentada en el GEAo (p=0,058). El DDVI fue igual en las 6&#170;, 12&#170; y 18&#170; semanas, superiores a la 3&#170; semana en ambos grupos. Esta variable fue menor en el GEAo, cuando se la compara la GC. La relaci&#243;n DDVI/PC en el GC y en el GEAo fue mayor en la 3&#170; semana con relaci&#243;n a las dem&#225;s semanas, siendo las 12&#170; y 18&#170; semanas inferiores a la 6&#170; semana. No hubo diferencia entre los grupos. El DSVI fue superior en las 6&#170; y 12&#170; semanas con relaci&#243;n a la 3&#170; en el GC. En el GEAo, el DSVI aumento en las 6&#170;, 12&#170; y 18&#170; semanas con relaci&#243;n a la 3&#170;, siendo la 18&#170; diferente de la 6&#170; semana. El DSVI fue menor en el GEAo con relaci&#243;n al GC.</p>
      <p content-type="asset">
        <table-wrap id="es_11t02-body3">
          <graphic xlink:href="1678-4170-abc-94-01-0062-00011-gt02-es.jpg"/></table-wrap>
      </p>
      <p>Las EDPP y EDSIV no se alteraron en el GC durante el per&#237;odo experimental; aumentaron en los momentos 12 y 18 con relaci&#243;n a los momentos 3 y 6 en los animales del GEAo. Estos par&#225;metros fueron superiores en el GEAo con relaci&#243;n al GC en todos los momentos. La ErelVI no se alter&#243; en el GC; la 18&#170; semana diferi&#243; de la 6&#170; semana en el GEAo. Esta variable fue mayor en el GEAo que en el GC en todas las semanas. No hubo variaci&#243;n del AI en el GC, aunque hubiera una tendencia a ser mayor en las 12&#170; (p=0,075) y 18&#170; (p=0,063) semanas con relaci&#243;n a la 3&#170; semana; en el GEAo, el AI fue mayor a partir de la semana 6, no sufriendo posterior variaci&#243;n. El AI present&#243; valores m&#225;s elevados en el GEAo que en el GC a partir de la 6&#170; semana. La relaci&#243;n AI/PC fue inferior en las 6&#170;, 12&#170; y 18&#170; semanas - menores que la semana 6 en ambos grupos cuando se las compara a la 3&#170; y a las 12&#170; y 18&#170; semanas. Esta relaci&#243;n fue mayor en el GEAo que en el GC en todos los per&#237;odos. El AO en el GC en las 6&#170; y 12&#170; semanas fue diferente de la 3&#170; semana. La 18&#170; semana diferi&#243; de todas las anteriores. En el GEAo, las 6&#170;, 12&#170; y 18&#170; semanas fueron superiores a la 3&#170; semana. Esta variable fue menor en el GEAo con relaci&#243;n al GC en la 18&#170; semana. No hubo variaci&#243;n en la relaci&#243;n AI/AO entre los diferentes momentos en ambos grupos. Aunque el grupo GEAo haya presentado aumento del AI/AO con relaci&#243;n al GC, s&#243;lo en la 18&#170; semana hubo una tendencia de los valores del GEAo a ser mayhores que el GC (0,07&gt;p&lt;0,13). Los datos absolutos y relativos del AI muestran que esta c&#225;mara sufri&#243; una remodelaci&#243;n significativa a partir de la 6&#170; semana.</p>
      <p>
        <bold>Evaluaci&#243;n ecocardiogr&#225;fica de la funci&#243;n sist&#243;lica y diast&#243;lica del ventr&#237;culo izquierdo</bold>
      </p>
      <p>En las <xref ref-type="table" rid="es_11t03-body3">Tablas 3</xref> y <xref ref-type="table" rid="es_11t04-body3">4</xref> se describen respectivamente, la FC y los par&#225;metros de la evaluaci&#243;n funcional sist&#243;lica y diast&#243;lica del VI. No se observaron diferencias en la FC entre grupos y momentos. No hubo diferencia en el &#916;D endo y meso en funci&#243;n del tiempo en el GC. En el GEAo, la &#916;D endo de la 12&#170; semana fue menor que la de la 3&#170; y mayor que la de la 18&#170; semana, menor que la 3&#170; y la 6&#170; semanas. La &#916;D meso en el GEAo fue menor en la 18&#170; semana con relaci&#243;n a la 3&#170; y 6&#170;. Las &#916;D endo y meso fueron mayores en el GEAo que en el GC en todos los momentos, con excepci&#243;n de la 18&#170; semana, en que el &#916;D meso fue igual en ambos grupos (<xref ref-type="table" rid="es_11t03-body3">Tabla 3</xref>). En las <xref ref-type="fig" rid="f1-body3">Figuras 1</xref> y <xref ref-type="fig" rid="f2-body3">2</xref>, se puede visualizar que, mientras la &#916;D endo y meso no se alteraron en el GC, en el GEAo hubo una ca&#237;da de estos &#237;ndices durante la evoluci&#243;n del proceso, volvi&#233;ndose significativos a partir de la 12&#170; semana en el &#916;D endo y en la 18&#170; en el &#916;D meso.</p>
      <p content-type="asset">
        <table-wrap id="es_11t03-body3">
          <graphic xlink:href="1678-4170-abc-94-01-0062-00011-gt03-es.jpg"/></table-wrap>
      </p>
      <p content-type="asset">
        <table-wrap id="es_11t04-body3">
          <graphic xlink:href="1678-4170-abc-94-01-0062-00011-gt04-es.jpg"/></table-wrap>
      </p>
      <fig id="f1-body3">
        <graphic xlink:href="1678-4170-abc-94-01-0062-00011-gf01-es.jpg"/></fig>
      <fig id="f2-body3">
        <graphic xlink:href="1678-4170-abc-94-01-0062-00011-gf02-es.jpg"/></fig>
      <p>La VEPP, cuando se eval&#250;a intragrupo, se mostr&#243; significativamente mayor en la 18&#170; semana con relaci&#243;n a las 3&#170; y 6&#170; semanas en el GC, y no alterada en el GEAo. Hubo reducci&#243;n del VEPP en el GEAo con relaci&#243;n al GC en la 18&#170; semana. El DC aumento en las 12&#170; y 18&#170; semanas con relaci&#243;n a la 3&#170; en el GC, con tendencia a ser superior en la 6&#170; semana con relaci&#243;n a la 3&#170; (p=0,083). En el GEAo, las 6&#170;, 12&#170; y 18&#170; semanas fueron superiores a la 3&#170;. Hubo diferencia en el DC entre grupos s&#243;lo en la 18&#170; semana, siendo menor en el GEAo. El InC disminuy&#243; en la 12&#170; y 18&#170; semanas en el GC con relaci&#243;n a las semanas anteriores. En el GEAo, la 18&#170; semana fue menor que las 3&#170; y 6&#170; semanas. Hubo una tendencia de la 12&#170; semana a ser menor que la 6&#170; semana (p=0,069). No hubo diferencia entre los grupos (<xref ref-type="table" rid="es_11t03-body3">Tabla 3</xref>).</p>
      <p>En el GC y GEAo (<xref ref-type="table" rid="es_11t04-body3">Tabla 4</xref>), las ondas E y A no presentaron alteraciones en los diferentes per&#237;odos de evaluaci&#243;n. Mientras la onda E fue igual intergrupos, la onda A fue mayor en el GEAo que en el GC en todos los per&#237;odos. La relaci&#243;n E/A present&#243; disminuci&#243;n en el GC en la 18&#170; semana con relaci&#243;n a la 3&#170;, con tendencia a ser menor en la 18&#170; semana con relaci&#243;n a la 6&#170; (p=0,067) y 12&#170; (p=0,095) semanas. En el GEAo no hubo diferencia entre los momentos, con tendencia a la diferencia entre las 3&#170; y 18&#170; semanas (p=0,10). La relaci&#243;n E/A se mostr&#243; superior en el GC en los diferentes momentos evaluados (<xref ref-type="table" rid="es_11t04-body3">Tabla 4</xref> y <xref ref-type="fig" rid="f3-body3">Figura 3</xref>). El TRIV fue similar en el GC en todos los momentos. En el GEAo, fue mayor en la 18&#170; semana con relaci&#243;n a la 3&#170; y 6&#170;. No hubo diferencia entre los grupos. El TDE fue similar en el GC. En el GEAo hubo tendencia a la diferencia entre las 6&#170; y 18&#170; semanas (p=0,058) y 12&#170; y 18&#170; semanas (p=0,063). El TDE fue menor en el GEAo en los momentos 3, 12 y 18 con relaci&#243;n al GC.</p>
      <fig id="f3-body3">
        <graphic xlink:href="1678-4170-abc-94-01-0062-00011-gf03-es.jpg"/></fig>
      <p>
        <bold>Discusi&#243;n</bold>
      </p>
      <p>En este estudio se evaluaron la morfolog&#237;a y la funci&#243;n card&#237;aca durante el proceso de remodelaci&#243;n en ratones sometidos a EAo. La remodelaci&#243;n que ocurre frente a esa agresi&#243;n puede acarrear disfunci&#243;n ventricular. El principal criterio para el diagn&#243;stico de esa alteraci&#243;n funcional, en estudios experimentales, ha sido el nivel de la presi&#243;n final diast&#243;lica del VI, evaluado por m&#233;todo hemodin&#225;mico<sup>18</sup>. No obstante, su determinaci&#243;n requiere un proceso invasivo, hecho que perjudica estudios longitudinales. Adem&#225;s de ello, la cateterizaci&#243;n del VI puede causar da&#241;os a la v&#225;lvula a&#243;rtica o afectar el desempe&#241;o card&#237;aco<sup>19</sup>.</p>
      <p>El ECO representa una alternativa para el estudio de la funci&#243;n ventricular y puede ofrecer importantes informaciones sobre desempe&#241;o card&#237;aco en roedores<sup>19</sup>. &#201;ste permite evaluar la morfolog&#237;a y la funci&#243;n card&#237;aca<sup>8,19-21</sup>, la evoluci&#243;n de la disfunci&#243;n ventricular causada por diferentes tipos de agresi&#243;n<sup>22</sup> y los efectos de diferentes intervenciones<sup>13,23</sup>. Es un m&#233;todo vers&#225;til, seguro, indoloro, no invasivo e importante para an&#225;lisis seriales <italic>in vivo</italic><sup>24</sup>.</p>
      <p>Los resultados ecocardiogr&#225;ficos en este estudio muestran importantes alteraciones estructurales del VI durante el proceso de la evoluci&#243;n de la remodelaci&#243;n<sup>25</sup>. El IMVI disminuy&#243; en el GC a partir de la 12&#170; semana en raz&#243;n del aumento del peso corporal de los ratones; en el GEAo el IMVI se mantuvo estable. Como este par&#225;metro no es directamente proporcional al peso corporal, en situaci&#243;n de p&#233;rdida o ganancia de peso corporal los valores normalizados estar&#225;n aumentados o disminuidos, respectivamente. Varios par&#225;metros indicadores de hipertrofia, como EDPP, EDSIV y ERelVI, se presentaron alterados a partir de la 3&#170; semana y el IMVI despu&#233;s de la 6&#170; semana. El an&#225;lisis de la ERelVI indic&#243; que la EAo result&#243;, precozmente, en hipertrofia conc&#233;ntrica del VI, mantenida hasta el final del experimento. La remodelaci&#243;n ventricular izquierda por el ECO fue confirmado por evaluaci&#243;n estructural card&#237;aca despu&#233;s del sacrificio de los ratones (<xref ref-type="table" rid="t1-body3">Tabla 1</xref>).</p>
      <p>Adem&#225;s de la hipertrofia ventricular izquierda, los resultados muestran que los ratones del GEAo, al momento del sacrificio, presentaban una hipertrofia del ventr&#237;culo derecho evaluada por la relaci&#243;n VD/PC. A pesar de que el diagn&#243;stico de insuficiencia card&#237;aca, en este experimento, se realiz&#243; por la asociaci&#243;n de las se&#241;ales cl&#237;nicas morfol&#243;gicas, descritas anteriormente, el hallazgo aislado del aumento de esta relaci&#243;n no significa que los ratones del GEAo estar&#237;an con insuficiencia card&#237;aca. Sin embargo, los aumentos del peso atrial y de su relaci&#243;n con el peso corporal muestran que los ratones, al momento del sacrificio, presentaban disfunci&#243;n ventricular izquierda.</p>
      <p>Los datos estructurales del VI, determinados por ECO o post sacrificio, est&#225;n de acuerdo con un sinn&#250;mero de trabajos que detectaron hipertrofia ventricular en diferentes fases del RC despu&#233;s de la inducci&#243;n de EAo<sup>4,6,8,11,12</sup>. Valores observados en el DSVI est&#225;n en desacuerdo con la bibliograf&#237;a, que no encontr&#243; alteraci&#243;n de esta variable en el GEAo despu&#233;s de la 6&#170; semana de inducci&#243;n de EAo<sup>4,19</sup>.</p>
      <p>El desarrollo de la hipertrofia ventricular izquierda fue una respuesta adaptativa a la elevaci&#243;n de la presi&#243;n intraventricular a la EAo, ya que el aumento del espesor de la pared y disminuci&#243;n de la cavidad pueden normalizar el estr&#233;s parietal y, por consiguiente, la funci&#243;n ventricular. La hipertrofia conc&#233;ntrica se deriva del aumento del di&#225;metro de los miocitos con poca o ninguna modificaci&#243;n en la longitud celular<sup>26</sup>. Concomitantemente, se observan modificaciones en las proporciones de los componentes intersticiales del miocardio, incluyendo acumulaci&#243;n de col&#225;geno en la musculatura ventricular<sup>27,28</sup>. El est&#237;mulo para el RC ocurre por factores mec&#225;nicos y bioqu&#237;micos que act&#250;an en los receptores, canales i&#243;nicos y en las integrinas presentes en la membrana sarcolemal que, activando se&#241;alizadores bioqu&#237;micos citos&#243;licos, desencadenan aumento de la s&#237;ntesis de prote&#237;nas y alteraciones en la expresi&#243;n g&#233;nica<sup>2,12</sup>.</p>
      <p>El an&#225;lisis de la funci&#243;n sist&#243;lica del VI mostr&#243; mejora de los &#916;D endo y &#916;D meso en el GEAo con relaci&#243;n al GC, que se deterioraron durante el proceso de remodelaci&#243;n. La disminuci&#243;n significativa del &#916;D endo en el GEAo ocurri&#243; a partir de la 12&#170; semana; la disminuci&#243;n del &#916;D meso fue significante en la 18&#170; (<xref ref-type="fig" rid="f1-body3">Figuras 1</xref> y <xref ref-type="fig" rid="f2-body3">2</xref>). A pesar de que estos &#237;ndices disminuyeron a lo largo del tiempo, &#233;stos se mantuvieron superiores en el GEAo, con excepci&#243;n de la 18&#170; semana, en la cual la &#916;D meso se igual&#243; en los dos grupos. Aunque el DC haya aumentado en los dos grupos entre las 3&#170; y 18&#170; semanas, la elevaci&#243;n fue menor en el GEAo que en el GC s&#243;lo en la 18&#170; semana. Otro par&#225;metro que analiza la funci&#243;n de eyecci&#243;n del coraz&#243;n, pero que toma en consideraci&#243;n el peso corporal, el InC, se mostr&#243; igual en ambos grupos. El an&#225;lisis de los diferentes &#237;ndices muestra que el m&#225;s sensible para la detecci&#243;n de la disfunci&#243;n sist&#243;lica fue el &#916;D endo, que detect&#243; una ca&#237;da significativa en la 12&#170; semana. Los otros dos &#237;ndices detectaron m&#225;s tard&#237;amente, en la 18&#170; semana.</p>
      <p>No se encontraron trabajos que evaluaran la funci&#243;n sist&#243;lica del VI secuencialmente en los mismos per&#237;odos analizados en este experimento (3&#170;, 6&#170;, 12&#170; y 18&#170; semanas). Autores que evaluaron la funci&#243;n card&#237;aca de ratones con EAo despu&#233;s de la 6&#170;, 12&#170; y 18&#170; semanas encontraron &#916;D endo supranormal en la 6&#170; semana y &#916;D meso disminuido en todos los per&#237;odos con relaci&#243;n al GC. Mientras que la &#916;D endo decreci&#243;, la &#916;D meso permaneci&#243; estable entre la 6&#170; y la 18&#170; semanas en el GEAo<sup>8</sup>. Otro estudio observando la 6&#170;, 12&#170; y 21&#170; semanas encontr&#243; una ca&#237;da en el porcentaje de acortamiento en la 21&#170; semana<sup>9</sup>.</p>
      <p>La mejora de la funci&#243;n sist&#243;lica en el GEAo con relaci&#243;n al GC debe estar relacionada al desarrollo de la hipertrofia conc&#233;ntrica, normalizaci&#243;n de la tensi&#243;n sist&#243;lica y mantenimiento de los l&#237;mites fisiol&#243;gicos del consumo de ox&#237;geno de las fibras mioc&#225;rdicas<sup>2,16,19, 29</sup>. La p&#233;rdida progresiva de la funci&#243;n sist&#243;lica puede estar relacionada: 1) a la remodelaci&#243;n geom&#233;trica adverso de la cavidad<sup>30,31</sup>; 2) a alteraciones de la composici&#243;n del miocardio, como aumento de la matriz extracelular y disminuci&#243;n del n&#250;mero de miocitos, por necrosis o apoptosis<sup>16,31</sup>; 3) al compromiso de la contractilidad<sup>32</sup> o 4) a la combinaci&#243;n de estos factores<sup>2,19,28</sup>.</p>
      <p>La evaluaci&#243;n del desempe&#241;o diast&#243;lico mostr&#243; la ocurrencia de disfunci&#243;n precoz en el GEAo con relaci&#243;n al GC. A partir de la 3&#170; semana despu&#233;s de la inducci&#243;n de la EAo, en el grupo con sobrecarga pres&#243;rica ocurri&#243; un aumento de la onda A, reducci&#243;n de la relaci&#243;n E/A y del tiempo de desaceleraci&#243;n de la onda E (<xref ref-type="table" rid="es_11t04-body3">Tabla 4</xref> y <xref ref-type="fig" rid="f3-body3">Figura 3</xref>). Este dato muestra que la ca&#237;da de la funci&#243;n diast&#243;lica precede a la sist&#243;lica, que ocurri&#243; en la 12&#170; semana.</p>
      <p>No se encontraron experimentos que observaran la funci&#243;n diast&#243;lica en los per&#237;odos evaluados en esta investigaci&#243;n. Litwin et al<sup>8</sup> encontraron en el GEAo aumento de la onda E en las 6&#170;, 12&#170; y 18&#170; semanas y disminuci&#243;n de la onda A en la 18&#170; semana, al compararlo con el GC. La relaci&#243;n E/A fue mayor en el GEAo que en el GC en las 12&#170; y 18&#170; semanas. Los autores concluyen que la EAo promovi&#243; una disfunci&#243;n diast&#243;lica del tipo restrictriva a partir de la 6&#170; semana. Ribeiro et al<sup>9</sup> verificaron aumento de la relaci&#243;n E/A a partir de la 12&#170; semana en animales con EAo. El an&#225;lisis comparativo entre los trabajos de la bibliograf&#237;a y este experimento muestra que, aunque en ambos la disfunci&#243;n diast&#243;lica fuera un hecho consistente y precoz, el comportamiento de la relaci&#243;n E/A fue diferente. Mientras en esta investigaci&#243;n la relaci&#243;n E/A disminuy&#243;, los otros autores encontraron aumento de esta variable. Esta discrepancia de resultados tal vez se deba a dificultades t&#233;cnicas en la obtenci&#243;n de buenas im&#225;genes para an&#225;lisis de efecto Doppler y a la alta frecuencia card&#237;aca de estos animales, que funde las ondas E y A dificultando la mensuraci&#243;n de la funci&#243;n diast&#243;lica<sup>33,34</sup>.</p>
      <p>A pesar de la diferencia de los valores de la relaci&#243;n E/A con la bibliograf&#237;a, el di&#225;metro del AI, aisladamente, se mostr&#243; aumentado a partir de la 6&#170; semana, y al normalizarlo por el peso corporal, se present&#243; superior al GC desde la 3&#170; semana; la relaci&#243;n AI/AO indic&#243; tendencia a ser mayor en el GEAo a partir de la 3&#170; semana (0,07&lt;p&gt;0,13). Por lo tanto, la remodelaci&#243;n del AI en la 3&#170; o 6&#170; semana refleja disfunci&#243;n diast&#243;lica del VI, desde que el desempe&#241;o sist&#243;lico se mostr&#243; mejorado en el GEAo con relaci&#243;n al GC en estos dos momentos. Estos datos est&#225;n de acuerdo con otros autores<sup>4,11</sup> que constataron aumento de esta variable.</p>
      <p>El deterioro de la funci&#243;n diast&#243;lica observada en este estudio puede estar relacionado con las alteraciones de las propiedades el&#225;sticas y a disturbios en el manejo del calcio intracelular. Estudios experimentales asociaron el aumento de la rigidez mioc&#225;rdica en la EAo a la elevaci&#243;n de la deposici&#243;n de las fibras col&#225;genas<sup>29,35</sup>. Las alteraciones de las prote&#237;nas relativas a la recaptura del calcio intracelular, principalmente la bomba de calcio del ret&#237;culo sarcoplasm&#225;tico, tambi&#233;n se han relacionado con la ca&#237;da del desempe&#241;o diast&#243;lico en la EAo<sup>29</sup>.</p>
      <p>El estudio de la funci&#243;n diast&#243;lica del VI es de gran importancia, teniendo en vista que las alteraciones en el llenado de esta cavidad pueden anteceder a la disfunci&#243;n sist&#243;lica<sup>36</sup>. Actualmente, la forma m&#225;s viable y factible de evaluaci&#243;n de la funci&#243;n diast&#243;lica es el an&#225;lisis de las velocidades del flujo transmitral, durante la fase inicial del llenado diast&#243;lico del ventr&#237;culo izquierdo, representado por la onda E, y del llenado ventricular durante la contracci&#243;n atrial, expresada por la onda A. De la misma forma, se pueden obtener valores referentes a la relaci&#243;n E/A, al tiempo de desaceleraci&#243;n de la onda E y al tiempo de relajaci&#243;n isovolum&#233;trica (TRIV)<sup>25</sup>. La observaci&#243;n de valores menores de onda E y de la relaci&#243;n E/A, cuando se comparan con el grupo contro, sugiere la presencia de disfunci&#243;n diast&#243;lica<sup>37</sup>. Otra forma de determinaci&#243;n de la severidad de la disfunci&#243;n diast&#243;lica es la evaluaci&#243;n del atrio izquierdo por ecocardiograf&#237;a<sup>38</sup>. Durante la di&#225;stole ventricular, el AI est&#225; expuesto directamente a presiones intraventriculares por medio de la v&#225;lvula mitral abierta. Las eventuales elevaciones de presiones de llenado ventricular conllevan un aumento del volumen y de la presi&#243;n atrial<sup>38</sup> y consiguiente remodelaci&#243;n atrial.</p>
      <p>
        <bold>Conclusi&#243;n</bold>
      </p>
      <p>Se concluye, despu&#233;s del examen de los datos de este trabajo, que: 1) el ventr&#237;culo izquierdo de los ratones con EAo, durante el proceso de remodelaci&#243;n, presenta hipertrofia conc&#233;ntrica, disfunci&#243;n diast&#243;lica precoz y mejora de la funci&#243;n sist&#243;lica, con posterior deterioro del desempe&#241;o; 2) los &#237;ndices ecocardiogr&#225;ficos m&#225;s sensibles para la detecci&#243;n de la disfunci&#243;n diast&#243;lica y sist&#243;lica son, respectivamente, la relaci&#243;n E/A y el porcentaje de acortamiento endoc&#225;rdico.</p>
      <p>
        <bold>Potencial Conflicto de Intereses</bold>
      </p>
      <p>Declaro no haber conflicto de intereses pertinentes.</p>
      <p>
        <bold>Fuentes de Financiaci&#243;n</bold>
      </p>
      <p>El presente estudio no tuvo fuentes de financiaci&#243;n externas.</p>
      <p>
        <bold>Vinculaci&#243;n Acad&#233;mica</bold>
      </p>
      <p>Este art&#237;culo forma parte de la tesis de Maestr&#237;a de Olga de Castro Mendes del Departamento de Cl&#237;nica M&#233;dica de la Facultad de Medicina de Botucatu.</p>
      <p>
        <bold>Refer&#234;ncias</bold>
      </p>
    </body>
  </sub-article>
</article>
